Publikationsliste: 2006-2024

Gomes M, Turner A, Sammon C, Ramagopalan S, Simpson A, Siebert U. Acceptability of using Real-World Data to Estimate Relative Treatment Effects in Health Technology Assessments: Barriers and Future Steps. Value in Health. February 16, 2024. https://doi.org/10.1016/j.jval.2024.01.020.

Egelseer-Bruendl T, Jahn B, Arvandi M, Puntscher S, Santamaria J, Brunelli L, Weissenegger K, Pfeifer B, Neururer S, Rissbacher C, Huber A, Fetz B, Kleinheinz C, Modre-Osprian R, Kreiner K, Siebert U, Poelzl G. Cost-Effectiveness of a Multidimensional Post-Discharge Disease Management Program for Heart Failure Patients—Economic Evaluation Along a One-Year Observation Period. Clinical Research in Cardiology (2024/02/14). https://dx.doi.org/10.1007/s00392-024-02395 5 

Rietjens J, Griffioen I, Sierra-Pérez J, Sroczynski G, Siebert U, Buyx A, Peric B, Svane I, Brands J, Steffensen K, Romero Piqueras C, Hedayati E, Karsten M, Couespel N, Akoglu C, Pazo-Cid R, Rayson P, Lingsma H, Schermer M, Steyerberg E, Payne S, Korfage IJ, Stiggelbout A. Improving shared decision-making about cancer treatment through design-based data-driven decision-support tools and redesigning care paths: an overview of the 4D PICTURE project. Palliat Care Soc Pract. 2024 Feb 12;18:26323524231225249. doi: 10.1177/26323524231225249. PMID: 38352191; PMCID: PMC10863384.

Litt J, Coll-Planas L, Sachs A, Rochau U, Jansson A, Dostálová V, Daher C, Beacom A, Bachinski K, Garcia Velez G, Bekessy S, Blancafort Alias S, Hill N, Gascón M, Bartova A, Cattaneo L, Cucchiaro A, Casajuana Kögel C, Opacin N, Colom J, Gentile S, Holmerová I, Johnson K, Kimberlee R, Siebert U, Varda D, Pitkälä K. Nature-based social interventions for people experiencing loneliness: the rationale and overview of the RECETAS project. Cities & Health. 2024:1-14. https://doi.org/10.1080/23748834.2023.2300207.

Coll-Planas L, Carbó-Cardeña A, Jansson A, Dostálová V, Bartova A, Rautiainen L, Kolster A, Masó-Aguado M, Briones-Buixassa L, Blancafort-Alias S, Roqué-Figuls M, Sachs A, Casajuana C, Siebert U, Rochau U, Puntscher S, Holmerová I, Pitkala K, Litt J. Nature-based social interventions to address loneliness among vulnerable populations: a common study protocol for three related randomized controlled trials in Barcelona, Helsinki, and Prague within the RECETAS European project. BMC Public Health. 2024;24(1):172. https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-023-17547-x.

Breeze P, Squires H, Ennis K, Meier P, Hayes K, Lomax N, Shiell A, Kee F, O'Flaherty M de Vocht F, Gilbert N, Robinson S Purshouse R, Dodd P, Strong M, Paisley S, Smith R, Briggs A, Occhipinti J Shahab L, Lawson K, Bayley T, Smith R, Kadirkamanathan V Boyd J, Cookson R, Hernandez-Alava M, Jackson C, Karapici A, Scarborough P Sassi F, Siebert U, Silverman E, Vale L, Walsh C, Brennan A. Guidance on the Use of Complex Systems Models for Economic Evaluations of Public Health Interventions. Health Econ 32, no. 7 (Jul 2023): 1603-25. https://dx.doi.org/10.1002/hec.4681.

Brunner C, Marth C, Egle D, Ritter M, Emmelheinz M Baumgart F, Walch B, Iannetti C, Zabernigg A, Andraschofsky T Castellan M, Markl A, Schnallinger M Hubalek M, Woell E, Puntscher S, Arvandi M, Siebert U, Bruckmoser E, Laimer J. Multicenter, Retrospective Population-Based Study on the Incidence of Medication-Related Osteonecrosis of the Jaw in Patients with Breast Cancer with Bone Metastases. Journal of Clinical Oncology 41, no. 16_suppl (2023): 6588-88 https://dx.doi.org/10.1200/JCO.2023.41.16_suppl.6588.

Götsch C, Voithofer C, Flatscher Thöni M. Zur Verortung der Uterustransplantation im österreichischen OTPG und FMedG. Journal für Medizin- und Gesundheitsrecht - JMG, Heft 1, März 2023, Band 8 (2023): 55-61. https://dx.doi.org/https://doi.org/10.33196/jmg202301005501.

Efficace F, Koinig K, Cottone F, Bowen D, Mittelman M, Langemeijer S Sommer K, Culligan D, Filanovsky K, Storck M, Smith A, Dugas M, Marrewijk van C, Stojkov I, Siebert U, Witte de T, Stauder R. Raising the standards of patient-centered outcomes research in myelodysplastic syndromes: Clinical utility and validation of the subscales of the QUALMS from the MDS-RIGHT project. Cancer Medicine Med. 2023 Mar; 12(6):7529-7539. doi: 10.1002/cam4.5487. Epub 2022 Dec 19. PMID: 36533415; PMCID: PMC10067097. (2023).

Elbel J, Nowak D, Böse-O'Reilly S, Hrzic R. A European Union Corporate Due Diligence Act for Whom? Considerations About the Impact of a European Union Due Diligence Act on Artisanal and Small-Scale Cobalt Miners in the Democratic Republic of Congo. Resources Policy 81 (2023/03/01/2023): 103241. https://dx.doi.org/https://doi.org/10.1016/j.resourpol.2022.103241.

Gartlehner G, Schernhammer E, Lax S, Preusser M, Bachler H, Tietzer H, Turnher H, Kletecka-Pulker M, Siebert U. Screening for Colorectal Cancer: A Recommendation Statement of the Austrian National Committee for Cancer Screening. Wien Klinische Wochenschrift (May 31 2023) https://dx.doi.org/10.1007/s00508-023-02209-0.

Götsch C, Böttcher B, Flatscher Thöni M. Utertustransplantation – Noch Im Experimentalstadium. Deutsches Ärzteblatt 120(5):A-191/B—168. (2023). https://www.aerzteblatt.de/archiv/229676/Uterustransplantation-Noch-im-Experimentalstadium.

Hallsson L, Sroczynski G, Engel J, Siebert U. Decision-Analytic Evaluation of the Comparative Effectiveness and Cost-Effectiveness of Strategies to Prevent Breast and Ovarian Cancer in German Women with Brca-1/2 Mutations. BMC Cancer 23, no. 1 (2023/06/26 2023): 590. https://dx.doi.org/10.1186/s12885-023-10956-6.

Haslwanter V, Rochau U, Schönherr H, Siebert U, Oberaigner W. A Population-Based Cohort of Adult Patients with Diabetes Mellitus in a Western District of Austria: The Diabetes Landeck Cohort. Endocrinol Diabetes Metab 6, no. 2 (Mar 2023): e395. https://dx.doi.org/10.1002/edm2.395.

Jankowska E, Andersson T, Bozkurt B Kaiser-Albers C, Chioncel O, Coats A, Hill L, Koehler F, Lund L, McDonagh T, Metra M, Mittmann C, Mullens W, Siebert U, Solomon S, McMurray J, Volterrani M. Optimizing Outcomes in Heart Failure: 2022 and Beyond. ESC Heart Fail (Apr 14 2023). https://dx.doi.org/10.1002/ehf2.14363.

Juneau C, Briand A, Collazzo P, Siebert U, Pueyo T. Effective Contact Tracing for Covid-19: A Systematic Review. Glob Epidemiol. Global Epidemiology 5 (2023/12/01/ 2023): 100103. 2023 Dec; 5:100103.
doi:  10.1016/j.gloepi.2023.100103. Epub 2023 Mar 9. PMID: 36959868; PMCID: PMC9997056. https://dx.doi.org/https://www.egms.de/static/en/journals/gms/2022-20/000314.shtml.

Guerra-Alejos B, Kurz M, Min J, Dale L, Piske M, Bach P, Bruneau J, Gustafson P, Hu X, Kampman K, Korthuis P, Loughin T, Maclure M, Platt R, Siebert U, Socías M, Wood E, Nosyk B. Comparative Effectiveness of Urine Drug Screening Strategies Alongside Opioid Agonist Treatment in British Columbia, Canada: A Population-Based Observational Study Protocol. BMJ Open (2023). https://pubmed.ncbi.nlm.nih.gov/37258082/

Karch A, Chaturvedi M, Koester D, Bossuyt P, Gerke O, Hofner B, Jurke A, Luetgetmann M, Kretzschmar M, Mikolajczyk R, Reitsma J, Schneiderhan-Marra N, Siebert U, Stekly C, Ehret C, Ruebsamen N, Zapf A. "A Unified Framework Towards Diagnostic Test Development and Evaluation During Outbreaks of Emerging Infections This Preprint Is under Review at Nature Portfolio." Research Square - Under Review (2023).
https://dx.doi.org/https://doi.org/10.21203/rs.3.rs-2827292/v1.

Kühne F, Hallsson L, Arvandi M, Puntscher S, Jahn B, Sroczynski G, Siebert U. Vergleich der Effektivität von multiplen dynamischen Behandlungsstrategien unter Nutzung der Target-Trial-Emulierung. Prävention Gesundheitsforum (2023). Epub 12. Juni 2023.
https://dx.doi.org/https://doi.org/10.1007/s11553-023-01033-8.

Fischer M. Das Miteinander Unterschiedlicher Akteure in Der Seelsorglichen Begleitung. Wege Zum Menschen. Vandenhoeck & Ruprecht Ausgabe 4. 332-345. (2023). https://dx.doi.org/https://www.vr-elibrary.de/doi/10.13109/weme.2023.75.4.332.

Santonen T, Mahiout S, Alvito P, Apel P, Bessems J, Bil W, Borges T, Böse-O'Reilly S, Buekers J, Cañas Portilla A, Calvo A, de Alba González M, Domínguez-Morueco N, López M, Falnoga I, Gerofke A, Caballero M, Horvat M, Huuskonen P, Kadikis N, Kolossa-Gehring M, Lange R, Louro H, Martins C, Meslin M, Niemann L, Díaz S, Plichta V, Porras S, Rousselle C, Scholten B, Silva M, Šlejkovec Z, Tratnik J, Joksić A, Tarazona J, Uhl M, van Nieuwenhuyse A, Viegas S, Vinggaard A, Woutersen M, Schoeters G. How to Use Human Biomonitoring in Chemical Risk Assessment: Methodological Aspects, Recommendations, and Lessons Learned from Hbm4eu. Int J Hyg Environ Health 249 (Mar 2 2023): 114139. https://dx.doi.org/10.1016/j.ijheh.2023.114139.

Schnell-Inderst P, Conrads-Frank A, Stojkov I, Krenn C, Kofler L, Siebert U. Occupational Therapy for Persons with Cognitive Impairments. 2023 Apr 4; Pmid: 37260919; Pmcid: Pmc10227641.", Ger Med Sci 21 (2023): Doc02.
https://dx.doi.org/https://www.egms.de/static/en/journals/gms/2023-21/000316.shtml.

Sokoll P, Migliavaca C, Siebert U, Schmid D, Arvandi M. Prevalence of Mycoplasma Genitalium Infection among Hiv Prep Users: A Systematic Review and Meta-Analysis. Sex Transm Infect (Feb 9 2023). https://dx.doi.org/10.1136/sextrans-2022-055687.

Steigenberger C, Schnell-Inderst P, Flatscher-Thöni M, Plank L, Siebert U. Patient' and Social Aspects Related to Complementary Mistletoe Therapy in Patients with Breast Cancer: A Systematic Review Commissioned by the German Agency for Health Technology Assessment. 
Eur J Oncol Nurs 65 (Aug 2023):102338. https://dx.doi.org/10.1016/j.ejon.2023.102338.

Stojkov I, Rochau U, Conrads-Frank A, Arvandi M, Koinig K, Mittelman M, Schomaker M, Fenaux P, Bowen D, Sanz G, Langemeijer S, Malcovati L, Germing U, Madry K, Culligan D Guerci-Bresler A, Kotsianidis I, Sanhes L, Mills J, Puntscher S, Schmid D, Smith A, van Marrewijk C, Efficace F, de Witte T, Stauder R, Siebert U. Determinants of Low Health-Related Quality of Life in Patients with Myelodysplastic Syndromes: Eumds Registry Study. Blood Adv (Jan 6 2023). https://dx.doi.org/10.1182/bloodadvances.2022008360.

Sturzlinger H, Conrads-Frank A, Eisenmann A, Invansits S, Jahn B, Janzic A, Jelenc M, Kostnapfel T, Mencej Bedrac S, Mühlberger N, Siebert U, Sroczynski G, Assessment European Network for Health Technology. Stool DNA Testing for Early Detection of Colorectal Cancer: Systematic Review Using the Hta Core Model((R)) for Rapid Relative Effectiveness Assessment. Ger Med Sci 21 (2023): Doc06. https://dx.doi.org/10.3205/000320.

Veličković V, Carradice D, Boyle J, Hamady M, Cleveland T, Ignjatović A, Bogdanović D, Neequaye S, Savovic J, Siebert U. Umbrella Review and Meta-Analysis of Reconstructed Individual Patient Data of Mortality Following Conventional Endovascular and Open Surgical Repair of Infrarenal Abdominal Aortic Aneurysm. Expert Review of Cardiovascular Therapy (2023). https://dx.doi.org/Expert Rev Cardiovasc Ther. 2023 May; 21(5):347-356. doi: 10.1080/14779072.2023.2207009. Epub 2023 May 1. PMID: 37128666.

Weidener L, Fischer M. Artificial Intelligence Teaching as Part of Medical Education: Qualitative Analysis of Expert Interviews. Full paper (Journal Peer Review). JMIR Med Educ, 2023;9:e46428, 1-8. (2023). https://dx.doi.org/https://mededu.jmir.org/2023/1/e46428.

Weidener L, Fischer M. Teaching AI Ethics in Medical Education: A Scoping Review of Current Literature and Practices. Perspectives on Medical Education. 2023:12(1): 399–410. https://pmejournal.org/articles/10.5334/pme.954.

Steigenberger C, Windisch F, Vogler S. Barriers and Facilitators in Pricing and Funding Policies of European Countries That Impact the Use of Point-of-Care Diagnostics for Acute Respiratory Tract Infections in Outpatient Practices. Diagnostics (Basel). 2023:13(23):3596. https://www.mdpi.com/2075-4418/13/23/3596#.

Sroczynski G, Hallsson L, Mühlberger N, Jahn B, Rehms R, Hoffmann S, Crispin A, Lindoerfer D, Mansmann U, Siebert U. Long-term benefits and harms of early colorectal cancer screening in German individuals with familial cancer risk. Int J Cancer. 2023. https://doi.org/10.1002/ijc.34747.

Ricci H, Gaeta M, Franchi C, Poli A, Battino M, Dolci A, Schmid D, Ricci C. Fish Intake in Relation to Fatal and Non-Fatal Cardiovascular Risk: A Systematic Review and Meta-Analysis of Cohort Studies. Nutrients. 2023;15:4539. https://doi.org/10.3390/nu15214539.

Pilz M, Seyringer S, Hallsson L, Bottomley A, Jansen F, King M, Norman R, Rutten M, Verdonck-de Leeuw M, Siersema P, Gamper E, on behalf of the EORTC Qualitiy of Life Group. The EORTC QLU-C10D is a valid cancer-specific preference-based measure for cost-utility and health technology assessment in the Netherlands. The European Journal of Health Economics. 2023.

Karch A, Chaturvedi M, Koester D, Bossuyt P, Gerke O, Hofner B, Jurke A, Kretzschmar M, Luetgetmann M, Mikolajczyk R, Reitsma J, Schneiderhan-Marra N, Siebert U, Stekly C, Ehret C, Ruebsamen N, Zapf A.
A unified framework towards diagnostic test development and evaluation during outbreaks of emerging infections. This preprint is Under Review at Nature Portfolio. Research Square - Under Review. 2023.
https://www.researchsquare.com/article/rs-2827292/v1.

Crispin A, Rehms R, Hoffmann S, Lindoerfer D, Hallsson L, Jahn B, Mühlberger N, Sroczynski G, Siebert U, Mansmann U. Colorectal Cancer Screening for Persons With a Positive Family History—Evaluation of the FARKOR Program for the Secondary Prevention of Colorectal Cancer in Persons Aged 25 to 50. Dtsch Arztebl Int. 2023(Forthcoming - 2023 Nov 17:(Forthcoming):arztebl.m2023.0220. doi: 10.3238/arztebl.m2023.0220. Online ahead of print.

Kuehne F, Arvandi M, Hess LM, Faries DE, Matteucci Gothe R, Gothe H, Beyrer J, Zeimet AG, Stojkov I, Muehlberger N, Oberaigner W, Marth C, Siebert U. Causal analyses with target trial emulation for real-world evidence removed large self-inflicted biases: Systematic bias assessment of ovarian cancer treatment effectiveness. Journal of Clinical Epidemiology 2022: S0895-4356(22)00246-3. doi: 10.1016/j.jclinepi.2022.10.005. Online ahead of print.

Kuehne F, Schomaker M, Stojkov I, Jahn B, Conrads-Frank A, Siebert S, Sroczynski G, Puntscher S, Schmid D, Schnell-Inderst P, Siebert U. Causal Evidence in Health Decision Making: Methodological Approaches of Causal Inference and Health Decision Science. HTA Report Vol. 509-1. GMS German Medical Science — an Interdisciplinary Journal 2022 [in press].

Jahn B, Friedrich S, Behnke J, Engel J, Garczarek U, Münnich R, Pauly M, Wilhelm A, Wolkenhauer O, Zwick M, Siebert U, Friede T. Authors' response: on the role of data, statistics and decisions in a pandemic. Adv Stat Anal. 2022;106(3):403-405. doi: 10.1007/s10182-022-00460-w. 

Stojkov I, Conrads-Frank A, Rochau U, Koinig KA, Arvandi M, Puntscher S, van Marrewijk C, Fenaux P, Symeonidis A, Chermat F, Garelius H, Bowen D, Mittelman M, Mora E, de Witte T, Efficace F, Siebert U, Stauder R. Core set of patient-reported outcomes for myelodysplastic syndromes: an EUMDS Delphi study involving patients and hematologists. Blood Adv. 2022;6(1):1-12. doi: 10.1182/bloodadvances.2021004568. PMID: 34492684; PMCID: PMC8753222.

Veličković VM, Szilcz M, Milošević Z, Godfrey T, Siebert U. Cost-effectiveness analysis of superabsorbent wound dressings in patients with moderate-to-highly exuding leg ulcers in Germany. Int Wound J. 2022;19(2):447-459. doi: 10.1111/iwj.13645. Epub 2021 Aug 2. PMID: 34342156; PMCID: PMC8762557.

Kuehne F, Rochau U, Paracha N, Yeh JM, Sabate E, Siebert U. Estimating Treatment-Switching Bias in a Randomized Clinical Trial of Ovarian Cancer Treatment: Combining Causal Inference with Decision-Analytic Modeling. Med Decis Making. 2022 Feb;42(2):194-207. doi: 10.1177/0272989X211026288. Epub 2021 Oct 20. PMID: 34666553.

Steigenberger C, Flatscher-Thoeni M, Siebert U, Leiter AM. Determinants of willingness to pay for health services: a systematic review of contingent valuation studies. Eur J Health Econ. 2022:1–28. doi: 10.1007/s10198-022-01437-x. Epub ahead of print. PMID: 35166973; PMCID: PMC8853086.

Morgano GP, Mbuagbaw L, Santesso N, Xie F, Brozek JL, Siebert U, Bognanni A, Wiercioch W, Piggott T, Darzi AJ, Akl EA, Verstijnen IM, Parmelli E, Saz-Parkinson Z, Alonso-Coello P, Schünemann HJ. Defining decision thresholds for judgments on health benefits and harms using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) Evidence to Decision (EtD) frameworks: a protocol for a randomised methodological study (GRADE-THRESHOLD). BMJ Open. 2022;12(3):e053246. doi: 10.1136/bmjopen-2021-053246. PMID: 35273045; PMCID: PMC8915269.

Stahl-Gugger A, de Godoi Rezende Costa Molino C, Wieczorek M, Chocano-Bedoya PO, Abderhalden LA, Schaer DJ, Spahn DR, Orav EJ, Vellas B, da Silva JAP, Kressig RW, Egli A, Bischoff-Ferrari HA, DO-HEALTH Research Group. Prevalence and incidence of iron deficiency in European community-dwelling older adults: an observational analysis of the DO-HEALTH trial. Aging Clin Exp Res. 2022. doi: 10.1007/s40520-022-02093-0. Epub ahead of print. PMID: 35304704.

Jahn B, Friedrich S, Behnke J, Engel J, Garczarek U, Münnich R, Pauly M, Wilhelm A, Wolkenhauer O, Zwick M, Siebert U, Friede T. On the role of data, statistics and decisions in a pandemic. Adv Stat Anal. 2022:1-34. doi: 10.1007/s10182-022-00439-7. Epub ahead of print. PMID: 35432617; PMCID: PMC8988552.

Rainer LJ, Granbichler CA, Kobulashvili T, Kuchukhidze G, Rauscher C, Renz N, Langthaler PB, Braun M, Linehan C, Christensen J, Siebert U, Trinka E. Prevalence of comorbidities, and affective disorders in epilepsy: A latent class analysis approach. Epilepsy Res. 2022;182:106917. doi: 10.1016/j.eplepsyres.2022.106917. Epub 2022 Mar 31. PMID: 35390702.

Bicher M, Rippinger C, Zechmeister M, Jahn B, Sroczynski G, Mühlberger N, Santamaria-Navarro J, Urach C, Brunmeir D, Siebert U, Popper N. An iterative algorithm for optimizing COVID-19 vaccination strategies considering unknown supply. PLoS One 2022;17(5):e0265957. doi: 10.1371/journal.pone.0265957. PMID: 35499997; PMCID: PMC9060336.

Rainer L, Bachner F, Eglau K, Ostermann H, Siebert U, Zuba M. Comorbidities and COVID-19 hospitalization, ICU admission and hospital mortality in Austria: A retrospective cohort study. Wien Klin Wochenschr. 2022:1–12. doi: 10.1007/s00508-022-02036-9. Epub ahead of print. PMID: 35608673; PMCID: PMC9127813.

Micieli A, Singh N, Jahn B, Siebert U, Menon BK, Demchuk AM. Cost effectiveness of testing for CYP2C19 loss-of-function carriers following transient ischemic attack/minor stroke: A Canadian perspective. Int J Stroke 2022:17474930221111898. doi: 10.1177/17474930221111898. Epub ahead of print. PMID: 35739635.

Jahn B, Santamaria J, Dieplinger H, Binder CJ, Ebenbichler C, Scholl-Bürgi S, Conrads-Frank A, Rochau U, Kühne F, Stojkov I, Todorovic J, James L, Siebert U. Familial hypercholesterolemia: A systematic review of modeling studies on screening interventions. Atherosclerosis 2022;355:15-29. doi: 10.1016/j.atherosclerosis.2022.06.1011. Epub ahead of print. PMID: 35870306.

Rainer L, Bachner F, Eglau K, Ostermann H, Siebert U. Zuba M. Comorbidities and COVID-19 hospitalization, ICU admission and hospital mortality in Austria. Wien Klin Wochenschr (2022). https://doi.org/10.1007/s00508-022-02036-9.

Asadi-Pooya, A, Patel A, Trinka E, Mazurkiewicz-Beldzinska M, Cross J, Welty T. Recommendations for Treatment Strategies in People with Epilepsy During Times of Shortage of Antiseizure Medications. Epileptic Disord. 2022 Oct 1;24(5):751-764. Doi: 10.1684/Epd.2022.1468. https://dx.doi.org/https://www.jle.com/fr/revues/epd/e-docs/recommendations_for_treatment_strategies_in_people_with_epilepsy_during_times_of_shortage_of_antiseizure_medications_322779/article.phtml.

Beuchat I, Rosenow F, Kellinghaus C, Trinka E, Unterberger I, Rüegg S, Sutter R, Tilz C, Uzelac Z, Rossetti A, Strzelczyk A. Refractory Status Epilepticus: Risk Factors and Analysis of Intubation in the Multicenter Sense Registry. Neurology 99, no. 16 (Oct 18 2022): e1824-e34. https://dx.doi.org/10.1212/wnl.0000000000201099.

Bischoff-Ferrari H, Freystatter G, Vellas B, Dawson-Hughes B, Kressig R, Kanis J, Willett W, Manson J, Rizzoli R, Theiler R, Hofbauer L, Armbrecht G, da Silva J, Blauth M, de Godoi Rezende Costa Molino C, Lang W, Siebert U, Egli A, Orav E, Wieczorek M, Do-Health Research Group. Effects of Vitamin D, Omega-3 Fatty Acids, and a Simple Home Strength Exercise Program on Fall Prevention: The Do-Health Randomized Clinical Trial. Am J Clin Nutr 115, no. 5 (May 1 2022): 1311-21. https://dx.doi.org/10.1093/ajcn/nqac022.

Herzog C, Sundstrom K, Jones A, Evans I, Barrett J, Wang J, Redl E, Schreiberhuber L, Costas L, Paytubi Dostalek L, Zikan M, Cibula D, Sroczynski G, Siebert U, Dillner J, Widschwendter M. DNA Methylation-Based Detection and Prediction of Cervical Intraepithelial Neoplasia Grade 3 and Invasive Cervical Cancer with the Wid-Qcin Test. Clin Epigenetics 14, no. 1 (Nov 21 2022):150.
https://dx.doi.org/10.1186/s13148-022-01353-0.

Jahn B, Sroczynski G, Bicher M, Rippinger C, Mühlberger N, Santamaria J, Urach C, Popper N, Siebert U. Covid 19 Vaccination - How to Support Decisions on Vaccination Prioritization for New Variants of Concern? Value in Health, Volume 25, Issue 12, Supplement, S263, December 2022. https://www.valueinhealthjournal.com/article/S1098-3015(22)03505-7/fulltext _returnURL=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS1098301522035057%3Fshowall%3Dtrue

Jahn B, Friedrich S, Behnke J, Engel J, Garczarek U, Munnich R, Pauly M, Wilhelm A, Wolkenhauer O, Zwick M, Siebert U, Friede T. On the Role of Data, Statistics and Decisions in a Pandemic. Adv Stat Anal  (7.04.2022): 1-34. https://dx.doi.org/10.1007/s10182-022-00439-7.

Molina-Pérez A, Werner-Felmayer G, Asche van K, Jensen A, Delgado J, Hannikainen I, Flatscher Thöni M, Rodriguez-Arias D, Schicktanz S, Wöhlke S. Attitudes of European Students Towards Family Decision-Making and the Harmonisation of Consent Systems in Deceased Organ Donation: A Cross-National Survey. BMC Public Health. 2022 Nov 15;22(1):2080. BMC Public Health 22, 2080 (2022) https://dx.doi.org/https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-022-14476-z.

Rainer L, Granbichler C, Kobulashvili T, Kuchukhidze G, Rauscher C, Renz N, Langthaler P, Braun M, Linehan C, Christensen J, Siebert U, Trinka E. Prevalence of Comorbidities, and Affective Disorders in Epilepsy: A Latent Class Analysis Approach. Epilepsy Research 182 (May 2022): 106917. https://dx.doi.org/10.1016/j.eplepsyres.2022.106917.

Singo J, Moyo D, Isunju J, Steckling-Muschack N, Böse-O'Reilly S, Becker J, Mamuse A. Health and Safety Risk Mitigation among Artisanal and Small-Scale Gold Miners in Zimbabwe. Int J Environ Res Public Health. 2022 Nov 2;19(21):14352. Doi: 10.3390/Ijerph192114352. Pmid: 36361232; Pmcid: Pmc9659187.", Int J Environ Res Public Health 19, no. 21 (Nov 2 2022). https://dx.doi.org/https://www.mdpi.com/1660-4601/19/21/14352.

Würzner P, Jörres R, Karrasch S, Quartucci C, Nowak D, Böse-O'Reilly S, Rakete S. Effect of Experimental Exposures to 3-D Printer Emissions on Nasal Allergen Responses and Lung Diffusing Capacity for Inhaled Carbon Monoxide/Nitric Oxide in Subjects with Seasonal Allergic Rhinitis. Indoor Air. 2022 Nov;32(11):E13174. https://onlinelibrary.wiley.com/doi/10.1111/ina.13174

Conrads-Frank A, Schnell-Inderst P, Neusser S, Hallsson L, Stojkov I, Siebert S, Kühne F, Jahn B, Siebert U, Sroczynski G. Decision-Analytic Modeling for Early Health Technology Assessment of Medical Devices - a Scoping Review. Ger Med Sci, 20 (2022): Doc11. https://pubmed.ncbi.nlm.nih.gov/36742459/

Kühne F, Arvandi M, Hess L, Faries D, Matteucci Gothe R, Gothe H, Beyrer J, Zeimet A, Stojkov I, Mühlberger N, Oberaigner W, Marth C, Siebert U. Causal Analyses with Target Trial Emulation for Real-World Evidence Removed Large Self-Inflicted Biases: Systematic Bias Assessment of Ovarian Cancer Treatment Effectiveness. J Clin Epidemiol, 152 (Dec 2022): 269-80. https://pubmed.ncbi.nlm.nih.gov/36252741/ 

Rippinger C, Bicher M, Urach C, Brunmeir D, Weibrecht N, Zauner G, Sroczynski G, Jahn B, Mühlberger N, Siebert U, Popper N. Evaluation of undetected cases during the COVID-19 epidemic in Austria. BMC Infectious Diseases 2021;21(1):70. doi: 10.1186/s12879-020-05737-6. PMID: 33441091; PMCID: PMC7805565.

Laimer J, Hechenberger M, Lercher JM, Born E, Schomaker M, Puntscher S, Siebert U, Bruckmoser E. New Perspective for Soft Tissue Closure in Medication-Related Osteonecrosis of the Jaw (MRONJ) Using Barbed Sutures. J Clin Med. 2021;10(8):1677. doi: 10.3390/jcm10081677. PMID: 33919696; PMCID: PMC8069803.

Schaffner M, Rochau U, Stojkov I, Qerimi Rushaj V, Völzke H, Marckmann G, Lazarus JH, Oberaigner W, Siebert U. Barriers Against Prevention Programs for Iodine Deficiency Disorders in Europe: A Delphi Study. Thyroid. 2021;31(4):649-657. doi: 10.1089/thy.2020.0065. PMID: 32912084..

Siebert U, Milev S, Zou D, Litkiewicz M, Gaggin HK, Tirapelle L, Masson S, Januzzi JL. Economic Evaluation of an N-terminal pro B-type Natriuretic Peptide-supported Diagnostic Strategy among Dyspneic Patients Suspected of Acute Heart Failure in the Emergency Department. Am J Cardiol. 2021;147:61-69. doi: 10.1016/j.amjcard.2021.01.036. PMID: 33617809.

Moonga G, Böse-O'Reilly S, Berger U, Harttgen K, Michelo C, Nowak D, Siebert U, Yabe J, Seiler J. Modelling chronic malnutrition in Zambia: A Bayesian distributional regression approach. PLoS One. 2021;16(8):e0255073. doi: 10.1371/journal.pone.0255073. PMID: 34347795; PMCID: PMC8336812.

Podgorica N, Flatscher-Thöni M, Deufert D, Siebert U, Ganner M. A systematic review of ethical and legal issues in elder care. Nursing Ethics 2021;28(6):895-910. doi:10.1177/0969733020921488.

Bicher M, Rippinger C, Urach C, Brunmeir D, Siebert U, Popper N.. Med Decis Making. 2021;41(8):1017-1032. doi: 10.1177/0272989X211013306. PMID: Evaluation of Contact-Tracing Policies against the Spread of SARS-CoV-2 in Austria: An Agent-Based Simulation 34027734.

Mühlberger N, Sroczynski G, Gogollari A, Jahn B, Pashayan N, Steyerberg E, Widschwendter M, Siebert U. Cost effectiveness of breast cancer screening and prevention: a systematic review with a focus on risk-adapted strategies. Eur J Health Econ. 2021;22(8):1311-1344. doi: 10.1007/s10198-021-01338-5. Epub 2021 Aug 3. PMID: 34342797.

Klompmaker S, de Rooij T, Koerkamp BG, Shankar AH, Siebert U, Besselink MG, Moser AJ; Dutch Pancreatic Cancer Group. International Validation of Reduced Major Morbidity After Minimally Invasive Distal Pancreatectomy Compared With Open Pancreatectomy. Ann Surg. 2021;274(6):e966-e973. doi: 10.1097/SLA.0000000000003659. PMID: 31756173.

Wouters HJCM, Conrads-Frank A, Koinig KA, Smith A, Yu G, de Witte T, Wolffenbuttel BHR, Huls G, Siebert U, Stauder R, van der Klauw MM; MDS-RIGHT partners. The anemia-independent impact of myelodysplastic syndromes on health-related quality of life. Ann Hematol. 2021;100(12):2921-2932. doi: 10.1007/s00277-021-04654-1. Epub 2021 Sep 2. PMID: 34476573; PMCID: PMC8592948.

Buchberger W, Oberaigner W, Kremser C, Gautsch K, Siebert U. Non-mass enhancement in breast MRI: Characterization with BI-RADS descriptors and ADC values. SciMedicine Journal 2021;3(2):77-87.

Schnell-Inderst P, Laschkolnig A, Marckmann G, Antony D, Siebert U, Mühlberger N. Hodenkrebsscreening bei Männern ab 16 Jahren: IQWiG ThemenCheck Health Technology Assessment-Bericht zu medizinischen, ökonomischen, sozialen, ethischen, rechtlichen und organisatorischen Aspekten [Testicular Cancer Screening in Men Aged 16 Years and Older: IQWiG ThemenCheck Health Technology Assessment Report on Medical, Economic, Social, Ethical, Legal and Organisational Aspects]. Gesundheitswesen. 2021. German. doi: 10.1055/a-1658-0057. Epub ahead of print. PMID: 34872119.

Schnell-Inderst P, Steigenberger C, Mertz M, Otto I, Flatscher-Thöni M, Siebert U. Administration of Mistletoe Preparations in Addition to Conventional Chemotherapy Compared to Conventional Chemotherapy Alone. Clinical Efficacy and Safety, Costs and Cost-Effectiveness, Patient and Social Aspects, and Ethical Assessment. [German; original title: Therapie mit Mistelextrakten bei Patientinnen mit Mammakarzinom als Ergänzung zur konventionellen Krebstherapie im Vergleich zur konventionellen Krebstherapie allein. Medizinische Wirksamkeit und Sicherheit, Kosten und Kosteneffektivität, Patienten- und soziale Aspekte, ethische Bewertung]. HTA Report Vol. 141 (Series commissioned by the Federal Ministry of Health in the Federal Republic of Germany). 338 pages. Cologne: Federal Institute of Drugs and Medical Devices (BfArM), 2021.

Steigenberger C, Schnell-Inderst P, Siebert U. Integrating patients and social aspects into health technology assessment. In: Schildmann J, Buch C, Zerth J, (eds.). Defining the Value of Medical Interventions: Normative and Empirical Challenges. W. Kohlhammer: Stuttgart, 2021;115-134.

Baumann FT, Reimer N, Gockeln T, Reike A, Hallek M, Ricci C, Zopf EM, Schmid D, Taaffe D, Newton RU, Galvao DA, Leitzmann M. Supervised pelvic floor muscle exercise is more effective than unsupervised pelvic floor muscle exercise at improving urinary incontinence in prostate cancer patients following radical prostatectomy - a systematic review and meta-analysis. Disabil Rehabil. 2021 Sep 22:1-12. doi: 10.1080/09638288.2021.1937717. Epub ahead of print. PMID: 34550846.

Jahn B, Sroczynski G, Bicher M, Rippinger C, Mühlberger N, Santamaria J, Urach C, Schomaker M, Stojkov I, Schmid D, Weiss G, Wiedermann U, Redlberger-Fritz M, Druml C, Kretzschmar M, Paulke-Korinek M, Ostermann H, Czasch C, Endel G, Bock W, Popper N, Siebert U. Targeted COVID-19 Vaccination (TAV-COVID) Considering Limited Vaccination Capacities-An Agent-Based Modeling Evaluation. Vaccines. 2021;9(5):434. . doi: 10.3390/vaccines9050434. PMID: 33925650.

Rippinger, C., Bicher, M., Urach, C., Brunmeir, D., Weibrecht, N., Zauner, G., Sroczynski, G., Jahn, B., Mühlberger, N., Siebert, U., & Popper, N. (2021). Evaluation of undetected cases during the COVID-19 epidemic in Austria. BMC Infect Dis, 21(1), 70. https://doi.org/10.1186/s12879-020-05737-6

Ammenwerth E, Neyer S, Hörbst A, Mueller G, Siebert U, Schnell-Inderst P. Adult patient access to electronic health records. The Cochrane database of systematic reviews. 2021; 2:Cd012707. doi: 10.1002/14651858.CD012707.pub2. PMID: 33634854.

Fiedler L, Hallsson L, Tscharre M, Oebel S, Pfeffer M, Schönbauer R, Tokarska L, Stix L, Haiden A, Kraus J, Blessberger H, Siebert U, Roithinger FX. Upstream Statin Therapy and Long-Term Recurrence of Atrial Fibrillation after Cardioversion: A Propensity-Matched Analysis. Journal of clinical medicine. 2021; 10(4):807. doi: 10.3390/jcm10040807. PMID: 33671264; PMCID: PMC7922984.

Fischer M. Zukunft der Seelsorge im Gesundheitswesen: Echter Verlag; 2021. 230 p. 

Schaffner M, Mühlberger N, Conrads-Frank A, Qerimi Rushaj V, Sroczynski G, Koukkou E, Heinsbaek Thuesen B, Völzke H, Oberaigner W, Siebert U, Rochau U. Benefits and Harms of a Prevention Program for Iodine Deficiency Disorders: Predictions of the Decision-Analytic EUthyroid Model. Thyroid. 2021; 31(3):494-508. 

Schaffner M, Rochau U, Mühlberger N, Conrads-Frank A, Qerimi Rushaj V, Sroczynski G, Koukkou E, Thuesen BH, Völzke H, Oberaigner W, Siebert U. The economic impact of prevention, monitoring and treatment strategies for iodine deficiency disorders in Germany. Endocrine connections. 2021; 10(1):1-12.  doi: 10.1530/EC-20-0384. PMID: 33263563; PMCID: PMC7849460.

Schmid D, Willett WC, Forman MR, Ding M, Michels KB. TV viewing during childhood and adult type 2 diabetes mellitus. Scientific reports. 2021; 11(1):5157. 

Steigenberger C, Schnell-Inderst P, Siebert U. Integrating patients and social aspects into health technology assessment.  Defining the Value of Medical Interventions: Normative and Empirical Challenges: Kohlhammer Verlag; 2021. p. 115-8. 

Stühlinger V, Werner-Felmayer G. Klinische Ethikberatung – eine spezielle Form der Begutachtung. Österreichische Zeitschrift für Geschichtswissenschaften. 2021; 31(3):144–56. 

Suraya A, Nowak D, Sulistomo AW, Icksan AG, Berger U, Syahruddin E, Bose-O'Reilly S. Excess Risk of Lung Cancer Among Agriculture and Construction Workers in Indonesia. Annals of global health. 2021; 87(1):8. 

Schomaker M, Kühne F, Siebert U. Re: "Effect Estimates in Randomized Trials and Observational Studies: Comparing Apples with Apples". [Letter]. Am J Epidemiol. 2020;189(1)77-78. pii: kwz194. doi: 10.1093/aje/kwz194.

Leitinger M, Trinka E, Zimmermann G, Granbichler CA, Kobulashvili T, Siebert U. Epidemiology of status epilepticus in adults: Apples, pears, and oranges — A critical review. Epilepsy & Behavior 2020;103 (Pt A): 106720. doi: 10.1016/j.yebeh.2019.106720.

Lechner C, Schnaiter D, Siebert U, Böse-O'Reilly S. Effects of Motorcycle Noise on Annoyance-A Cross-Sectional Study in the Alps. Int J Environ Res Public Health 2020; 17(5):1580. doi: 10.3390/ijerph17051580.

Gothe H, Matteucci Gothe R, Arvandi M, Hintringer K, Toell T, Oberaigner W, Rajsic S, Kugler J, Kiechl S, Willeit J, Siebert U. [Linkage of Clinical and Claims Data in the Evaluation of Post-Stroke Care – SeDaStro: Experiences from the Tyrolian StrokeCard Program]. [German]. Gesundheitswesen 2020; 82(S 02): S122-S130. PMID 32193880

Nussbaumer-Streit B, Mayr V, Dobrescu AI, Chapman A, Persad E, Klerings I, Wagner G, Siebert U, Christof C, Zachariah C, Gartlehner G. Quarantine alone or in combination with other public health measures to control COVID-19: a rapid review. Cochrane Database Syst Rev. 2020;4(4). Art. No.: CD013574. doi: 10.1002/14651858.CD013574. Update in: Cochrane Database Syst Rev. 2020;15;9:CD013574. PMID: 32267544; PMCID: PMC7141753.

Vukićević Đ, Rochau U, Savić A, Schaffner M, Jevđević M, Stojkov I, Sroczynski G, Willenbacher W, Jahn B, Siebert U. Long-Term Effectiveness and Cost Effectiveness of Multiple Myeloma Treatment Strategies for Elderly Transplant-Ineligible Patients in Serbia. Zdr Varst 2020;59(2):83-91. doi: 10.2478/sjph-2020-0011. PMID: 32952707

Stauder R, Lambert J, Desruol-Allardin S, Savre I, Gaugler L, Stojkov I, Siebert U, Chevrou-Séverac H. Patient-reported outcome measures in studies of myelodysplastic syndromes and acute myeloid leukemia: literature review and landscape analysis. European Journal of Haematology 2020; 104(5):476-487. PMID: 31985078

Sroczynski G, Gogollari S, Kuehne F, Hallsson L, Widschwendter M, Pashayan N, Siebert U. A systematic review on cost-effectivenes studies evaluating ovarian cancer early detection and prevention strategies. Cancer Prev Res (Phila). 2020;13(5):429-442. doi: 10.1158/1940-6207.CAPR-19-0506. PMID: 32071120.

Rochau U. Qerimi Rushaj V, Schaffner M, Schönhensch M, Stojkov I, Jahn B, Hubalewska-Dydejczyk A, Erlund I, H Thuesen B, Zimmermann M, Moreno-Reyes R, Lazarus JH, Völzke H, Siebert U. Decision-Analytic Modeling Studies in Prevention and Treatment of Iodine Deficiency and Thyroid Disorders: A Systematic Overview. Thyroid 2020;30(5):746-758. doi: 10.1089/thy.2018.0776. Epub 2020 Feb 26. PMID: 31964247.

Faulkner E, Holtorf AP, Walton S, Liu CY, Lin H, Biltaj E, Brixner D, Barr C, Oberg J, Shandhu G, Siebert U, Snyder SR, Tiwana S, Watkins J, IJzerman MJ, Payne K.. Being Precise About Precision Medicine: What Should Value Frameworks Incorporate to Address Precision Medicine? A Report of the Personalized Precision Medicine Special Interest Group. Value Health. 2020;23(5):529-539. doi: 10.1016/j.jval.2019.11.010. Epub 2020 Apr 1. Erratum in: Value Health. 2020 Nov;23(11):1522. PMID: 32389217.

Bose-O'Reilly S, Lettmeier B, Shoko D, Roider G, Drasch G, Siebert U. Infants and mothers levels of mercury in breast milk, urine and hair, data from an artisanal and small-scale gold mining area in Kadoma / Zimbabwe. Environ Res 2020;184:109266. doi: 10.1016/j.envres.2020.109266. Epub 2020 Feb 20. PMID: 32126374.

Hoffmann S, Crispin A, Lindoerfer D, Sroczynski G, Siebert U, Mansmann U, and FARKOR Consortium. Evaluating the effects of a risk-adapted screening program for familial colorectal cancer in individuals between 25 and 50 years of age: study protocol for the prospective population-based intervention study FARKOR. BMC Gastroenterol 2020; 20(1):131. doi: 10.1186/s12876-020-01247-6. PMID: 32370777; PMCID: PMC7201550.

Briggs A, Daniele B, Dick K, Jeffry Evans TR, Galle PR, Hubner RA, Lopez C, Siebert U, Tremblay G. Covariate-adjusted analysis of the Phase 3 REFLECT study of lenvatinib versus sorafenib in the treatment of unresectable hepatocellular carcinoma. Br J Cancer. 2020;122(12):1754-1759. doi:10.1038/s41416-020-0817-7. PMID: 32265508

Sroczynski G, Gogollari A, Conrads-Frank A, Hallsson LR, Pashayan N, Widschwendter M, Siebert U. Cost-effectiveness of early detection and prevention strategies for endometrial cancer-A systematic review. Cancers (Basel). 2020;12(7):1874. doi: 10.3390/cancers12071874. PMID: 32664613; PMCID: PMC7408795.

Schullian P, Gertl A, Laimer G, Putzer D, Siebert U, Levy E, Bale R. Quality of life analysis after stereotactic radiofrequency ablation of liver tumors. Sci Rep. 2020;10(1):12809. doi: 10.1038/s41598-020-69331-1. PMID: 32732877; PMCID: PMC7393379.

Sroczynski G, Esteban E, Widschwendter A, Oberaigner W, Borena W, von Laer D, Hackl M, Endel G, Siebert U. Reducing overtreatment associated with overdiagnosis in cervical cancer screening-A model-based benefit-harm analysis for Austria. Int J Cancer 2020;147(4):1131-1142. doi: 10.1002/ijc.32849. Epub 2020 Jan 13. PMID: 31872420.

Morawetz D, Blank C, Koller A, Arvandi M, Siebert U, Schobersberger W. Sex-Related Differences After a Single Bout of Maximal Eccentric Exercise in Response to Acute Effects: A Systematic Review and Meta-analysis. J Strength Cond Res. 2020;34(9):2697-2702. doi: 10.1519/JSC.0000000000002867. PMID: 30908366

Piske M, Thomson T, Krebs E, Hongdilokkul N, Bruneau J, Greenland S, Gustafson P, Karim ME, McCandless LC, Maclure M, Platt RW, Siebert U, Socías ME, Tsui JI, Wood E, Nosyk B. Comparative effectiveness of buprenorphine-naloxone versus methadone for treatment of opioid use disorder: a population-based observational study protocol in British Columbia, Canada. BMJ Open. 2020 Sep 9;10(9):e036102. doi: 10.1136/bmjopen-2019-036102. PMID: 32912944; PMCID: PMC7482450.

Latimer NR, White IR, Tilling K, Siebert U. Improved two-stage estimation to adjust for treatment switching in randomised trials: g-estimation to address time-dependent confounding. Stat Methods Med Res 2020;29(10):2900-2918. doi: 10.1177/0962280220912524. Epub 2020 Mar 30. PMID: 32223524; PMCID: PMC7436445.

Walter E, Hausberger SC, Groß E, Siebert U. Health-related quality of life, work productivity and costs related to patients with inflammatory bowel disease in Austria, Journal of Medical Economics 2020;23(10):1061-1071. doi: 10.1080/13696998.2020.1801187. Epub 2020 Aug 8. PMID: 32713223.

Pellecchia MT, Stankovic I, Fanciulli A, Krismer F, Meissner WG, Palma JA, Panicker JN, Seppi K, Wenning GK, Movement Disorder Society Multiple System Atrophy Study Group. Can Autonomic Testing and Imaging Contribute to the Early Diagnosis of Multiple System Atrophy? A Systematic Review and Recommendations by the Movement Disorder Society Multiple System Atrophy Study Group. Mov Disord Clin Pract. 2020;7(7):750-762. doi: 10.1002/mdc3.13052. PMID: 33043073; PMCID: PMC7533961.

Rochau U, Stojkov I, Conrads-Frank A, Borba HH, Koinig KA, Arvandi M, Marrewijk van C, Garelius H, Germing U, Symeonidis A, Sanz GF, Fenaux P, de Witte T, Efficace F, Siebert U, Stauder R. Development of a Core Outcome Set for Myelodysplastic Syndromes – A Delphi Study from the EUMDS Registry Group. Br J Haematol 2020 191(3):405-417. doi: 10.1111/bjh.16654. Epub 2020 May 14. PMID: 32410281.

Bischoff-Ferrari HA, Vellas B, Rizzoli R, Kressig RW, da Silva JAP, Blauth M, Felson DT, McCloskey EV, Watzl B, Hofbauer LC, Felsenberg D, Willett WC, Dawson-Hughes B, Manson JE, Siebert U, Theiler R, Staehelin HB, de Godoi Rezende Costa Molino C, Chocano-Bedoya PO, Abderhalden LA, Egli A, Kanis JA, Orav EJ; DO-HEALTH Research Group. Effect of Vitamin D Supplementation, Omega-3 Fatty Acid Supplementation, or a Strength-Training Exercise Program on Clinical Outcomes in Older Adults: The DO-HEALTH Randomized Clinical Trial. JAMA. 2020;324(18):1855-1868. doi: 10.1001/jama.2020.16909. PMID: 33170239; PMCID: PMC7656284.

Faries D, Zhang Z, Kadziola ZA, Siebert U, Kühne F, Obenchain RL, Haro JM. Real World Health Care Data Analysis: Causal Methods and Implementation Using SAS®. SAS Institute, 2020.

Leitinger M, Poppert KN, Mauritz M, Rossini F, Zimmermann G, Rohracher A, Kalss G, Kuchukhidze G, Höfler J, Bosque Varela P, Kreidenhuber R, Volna K, Neuray C, Kobulashvili T, Granbichler CA, Siebert U, Trinka E. Status epilepticus admissions during the COVID-19 pandemic in Salzburg-A population-based study. Epilepsia. 2020; 61(12):e198-e203. 

Mengel E, Gaedeke J, Gothe H, Krupka S, Lachmann A, Reinke J, Ohlmeier C. The patient journey of patients with Fabry disease, Gaucher disease and Mucopolysaccharidosis type II: A German-wide telephone survey. PloS one. 2020; 15(12):e0244279. 

Pashayan N, Antoniou AC, Ivanus U, Esserman LJ, Easton DF, French D, Sroczynski G, Hall P, Cuzick J, Evans DG, Simard J, Garcia-Closas M, Schmutzler R, Wegwarth O, Pharoah P, Moorthie S, De Montgolfier S, Baron C, Herceg Z, Turnbull C, Balleyguier C, Rossi PG, Wesseling J, Ritchie D, Tischkowitz M, Broeders M, Reisel D, Metspalu A, Callender T, de Koning H, Devilee P, Delaloge S, Schmidt MK, Widschwendter M. Personalized early detection and prevention of breast cancer: ENVISION consensus statement. Nat Rev Clin Oncol. 2020; 17(11):687-705. 

Rochau U, Stojkov I, Conrads-Frank A, Borba HH, Koinig KA, Arvandi M, van Marrewijk C, Garelius H, Germing U, Symeonidis A, Sanz GF, Fenaux P, de Witte T, Efficace F, Siebert U, Stauder R. Development of a core outcome set for myelodysplastic syndromes - a Delphi study from the EUMDS Registry Group. Br J Haematol. 2020; 191(3):405-17. 

Viswanathan M, Kahwati L, Jahn B, Giger K, Dobrescu AI, Hill C, Klerings I, Meixner J, Persad E, Teufer B. Universal screening for SARS-CoV-2 infection: a rapid review. Cochrane Database of Systematic Reviews. 2020; 9(9):1-75. 

Zhao T, Markevych I, Janßen C, Nowak D, Steckling-Muschack N, Heinrich J. Ozone exposure and health effects: a protocol for an umbrella review and effect-specific systematic maps. BMJ open. 2020; 10(8):e034854. 

Stausberg J, Maier B, Bestehorn K, Gothe H, Groene O, Jacke C, Jänicke M, Kostuj T, Mathes T, Niemeyer A, Olbrich K, Schmitt J, Neugebauer E. Memorandum Registry for Health Services Research: Update 2019. Gesundheitswesen (Bundesverband der Ärzte des Öffentlichen Gesundheitsdienstes (Germany)). 2020; 82(3):e39-e66. 

Stühlinger V. Health Technology Assessment (HTA) and Access Policies. European Journal of Health Law. 2020; 27(3):274–289. 

Suraya A, Nowak D, Sulistomo AW, Ghanie Icksan A, Syahruddin E, Berger U, Böse-O´Reilly S. Asbestos-Related Lung Cancer: A Hospital-Based Case-Control Study in Indonesia. Int J Environ Res Public Health 2020; 17(2):E591. 

Swart E, Gothe H, Hoffmann F, Ihle P, Schubert I, Stallmann C, March S. Sonderheft Methodische Aspekte der Sekundärdatenanalyse (I): Aufbereitung und Validierung verschiedener Sekundärdatenquellen. Gesundheitswesen (Bundesverband der Ärzte des Öffentlichen Gesundheitsdienstes (Germany)). 2020; 82(3):217-220. 

Swart E, Gothe H, Hoffmann F, Ihle P, Schubert I, Stallmann C, March S. Aufbereitung und Validierung verschiedener Sekundärdatenquellen. Gesundheitswesen (Bundesverband der Ärzte des Öffentlichen Gesundheitsdienstes (Germany)). 2020; 82(S 01):1-3. 

Swart E, Gothe H, Ihle P, March S, Schubert I, Stallmann C, Hoffmann F. Sonderheft Methodische Aspekte der Sekundärdatenanalyse (II): Datenlinkage und spezifische Methoden der Sekundärdatenanalyse. Gesundheitswesen (Bundesverband der Ärzte des Öffentlichen Gesundheitsdienstes (Germany)). 2020; 82(3):221-223.

Swart E, Gothe H, Ihle P, March S, Schubert I, Stallmann C, Hoffmann F. Sonderheft Methodische Aspekte der Sekundärdatenanalyse Gesundheitswesen (Bundesverband der Ärzte des Öffentlichen Gesundheitsdienstes (Germany)). 2020; 82(S 02):91-93. 

Sroczynski G, Gogollari A, Kuehne F, Hallsson LR, Widschwendter M, Pashayan N, Siebert U. A systematic Review on Cost-Effectiveness Studies evaluating Ovarian Cancer Early Detection and Prevention Strategies. Cancer prevention research (Philadelphia, Pa). 2020; 13(5):429-442. 

Schoierer J, Wershofen B, Böse-O’Reilly S, Mertes H. Hitzewellen und Klimawandel: Eine Herausforderung für Gesundheitsberufe. pubhef. 2020 ;28(1):54.

Podgorica N, Blerta Z, Ganner M, Flatscher-Thöni M. A Narrative Review on Legal Aspects of Older People in Albania. Journal of Educational and Social Research. 2020; 10(5):88-98. 

Ohlmeier C, Gothe H, Haas J, Osowski U, Weinhold C, Blauwitz S, Schmedt N, Galetzka W, Berkemeier F, Tackenberg B, Stangel M. Epidemiology, characteristics and treatment of patients with relapsing remitting multiple sclerosis and incidence of high disease activity: Real world evidence based on German claims data. PloS one. 2020; 15(5):e0231846. 

Rochau U, Qerimi Rushaj V, Schaffner M, Schönhensch M, Stojkov I, Jahn B, Hubalewska-Dydejczyk A, Erlund I, Thuesen BH, Zimmermann M, Moreno-Reyes R, Lazarus JH, Volzke H, Siebert U. Decision-Analytic Modeling Studies in Prevention and Treatment of Iodine Deficiency and Thyroid Disorders: A Systematic Overview. Thyroid. 2020; 30(5):746-758. 

Mühlberger N, Marckmann G, Laschkolnig A, Antony D, Sroczynski G, Jahn B, Schnell-Inderst P. HT18-01: Hodenkrebs: Führt eine regelmäßige Früherkennungsuntersuchung für Männer ab 16 Jahren zu besseren Behandlungsergebnissen? IQWiG-ThemenCheck, HTA-Bericht HT-1801. IQWIG. 934:292. 

Mayer S, Fischer C, Zechmeister-Koss I, Ostermann H, Simon J. Are Unit Costs the Same? A Case Study Comparing Different Valuation Methods for Unit Cost Calculation of General Practitioner Consultations. Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research. 2020; 23(9):1142-8.

Mambrey V, Rakete S, Tobollik M, Shoko D, Moyo D, Schutzmeier P, Steckling-Muschack N, Muteti-Fana S, Böse-O'Reilly S. Artisanal and small-scale gold mining: A cross-sectional assessment of occupational mercury exposure and exposure risk factors in Kadoma and Shurugwi, Zimbabwe. Environ Res. 2020; 184:109379. 

Magerl M, Ohlmeier C, Krupka S, Lachmann A, Gothe H. A Germany-wide survey study on the patient journey of patients with hereditary Angioedema. Orphanet journal of rare diseases. 2020; 15(1):221. 

Lorenzoni N, Stühlinger V, Stummer H, Raich M. Long-Term Impact of Disasters on the Public Health System: A Multi-Case Analysis. Int J Environ Res Public Health. 2020; 17:E6251. 

Lampe A, Werner-Felmayer G, Flatscher-Thöni M. Psychosoziale Aspekte in der Reproduktionsmedizin, in: Egle, Heim, Strauß, von Känel (Hrsg): Psychosomatische Medizin. Kohlhammer, 2020. 

Kerschberger B, Schomaker M, Jobanputra K, Kabore SM, Teck R, Mabhena E, Mthethwa-Hleza S, Rusch B, Ciglenecki I, Boulle A. HIV programmatic outcomes following implementation of the ‘Treat-All’ policy in a public sector setting in Eswatini: a prospective cohort study. J Int AIDS Soc. 2020; 23(3):e25458. 

Indelicato E, Nachbauer W, Eigentler A, Amprosi M, Matteucci Gothe R, Giunti P, Mariotti C, Arpa J, Durr A, Klopstock T, Schöls L, Giordano I, Bürk K, Pandolfo M, Didszdun C, Schulz JB, Boesch S. Onset features and time to diagnosis in Friedreich's Ataxia. Orphanet Journal of Rare Diseases. 2020; 15(1):198. 

Hoffmann S, Crispin A, Lindoerfer D, Sroczynski G, Siebert U, Mansmann U, Consortium F. Evaluating the effects of a risk-adapted screening program for familial colorectal cancer in individuals between 25 and 50 years of age: study protocol for the prospective population-based intervention study FARKOR. BMC gastroenterology. 2020; 20(1):131.  

Gothe H, Weber V, Brinkmann C, Ploner T, Ohlmeier C, Höer A, Lüftner D. Rückblick und Ausblick aus Sicht der Versorgungsforschung. In: Greiner W, Witte J, Gensorowsky D, Pauge S (Hrsg.): AMNOG-Report 2020. 10 Jahre AMNOG – Rückblick und Ausblick. Kap. 3.8. S. 156–168. In: Storm A (Hrsg.): Beiträge zur Gesundheitsökonomie und Versorgungsforschung (Band 32). September 2020. medhochzwei Verlag, Heidelberg. 

Gothe H, Swart E, Ihle P. Chancen und Risiken der Datennutzung im Gesundheitswesen aus Sicht der Versorgungsforschung. [Opportunities and risks of data use in the health care system from the perspective of health services research.] Gesundheit und Gesellschaft Wissenschaft. 2020; 20(3):7-13. 

Gothe H, Ohlmeier C. Inanspruchnahme von Versorgungsleistungen. In: Razum O, Kolip P (Hrsg.): Handbuch Gesundheitswissenschaften. S. 999–1016. 7., vollst. überarb. Auflage. Beltz-Juventa-Verlag, Weinheim und Basel. 

Gothe H, Brinkmann C, Schmedt N, Walker J, Ohlmeier C. Is there an unmet medical need for palliative care services in Germany? Incidence, prevalence, and 1-year all-cause mortality of palliative care sensitive conditions: real-world evidence based on German claims data. Journal of Public Health. 2020. 

Flatscher-Thöni M, Böttcher B, Geser W, Lampe A, Werner-Felmayer G, Voithofer C, Schusterschitz C. Worlds apart or two sides of the same coin? Attitudes, meanings, and motives of potential oocyte and sperm donors in Austria. Journal of Assisted Reproduction and Genetics. 2020; 37(2):287–296. 

Faries D, Zhang Z, Kadziola ZA, Siebert U, Kuehne F, Obenchain RL, Haro JM. Real World Health Care Data Analysis: Causal Methods and Implementation Using SAS®: Causal Methods and Implementation Using SAS®; SAS Institute; 2020. 436p. [F1]

Deering K, Spiegel E, Quaisser C, Nowak D, Rakete S, Garí M, Bose-O’Reilly S. Exposure assessment of toxic metals and organochlorine pesticides among employees of a natural history museum. Environmental Research. 2020; 184:109271. 

Butscher FM, Rakete S, Tobollik M, Mambrey V, Moyo D, Shoko D, Muteti-Fana S, Steckling-Muschack N, Bose-O'Reilly S. Health-related quality of life (EQ-5D + C) among people living in artisanal and small-scale gold mining areas in Zimbabwe: a cross-sectional study. Health and quality of life outcomes. 2020; 18(1):284. 

Böse-O´Reilly S, Lettmeier B, Shoko D, Roiderd G, Drasch G, Siebert U. Infants and mothers levels of mercury in breast milk, urine and hair, data from an artisanal and small-scale gold mining area in Kadoma/ Zimbabwe. Environmental Research 2020; 184:109266. 

Bell-Gorrod H, Court R, Schomaker M, Maartens G, Murphy RA. Increased Mortality With Delayed and Missed Switch to Second-Line Antiretroviral Therapy in South Africa. J Acquir Immune Defic Syndr. 2020; 84(1):107-113. 

Becker J, Böse-O'Reilly S, Shoko D, Singo J, Steckling-Muschack N. Comparing the self-reported health-related quality of life (HRQoL) of artisanal and small-scale gold miners and the urban population in Zimbabwe using the EuroQol (EQ-5D-3L+C) questionnaire: a cross-sectional study. Health and quality of life outcomes. 2020; 18(1):253. 

Schmid D, Song M, Zhang X, et al. Yogurt consumption in relation to mortality from cardiovascular disease, cancer, and all causes: a prospective investigation in 2 cohorts of US women and men. Am J Clin Nutr. 2020;111(3):689-697. doi:10.1093/ajcn/nqz345

Nussbaumer‐Streit B, Mayr V, Dobrescu AI, Chapman A, Persad E, Klerings I, Wagner G, Siebert U, Christof C, Zachariah C, Gartlehner G. Quarantine alone or in combination with other public health measures to control COVID‐19: a rapid review. Cochrane Database of Systematic Reviews 2020 Apr 8;4(4):CD013574. doi: 10.1002/14651858.CD013574.. https://pubmed.ncbi.nlm.nih.gov/32267544/.

Stürzlinger H, Conrads-Frank A, Eisenmann A, Ivansits S, Jahn B, Janzic A, Jelenc M, Kostnapfel T, Mencej Bedrac S, Mühlberger N, Rochau U, Siebert U, Schnell-Inderst P, Sroczynski G: Stool DNA testing for early detection of colorectal cancer.

Spizzo G, Siebert U, Gastl G, Voss A, Schuster K, Leonard R, Seeber A. Cost-comparison analysis of a multiplatform tumour profiling service to guide advanced cancer treatment. Cost Effectiveness and Resource Allocation. 2019; 17:23. 

Schomaker M, Luque Fernandez MA, Leroy V, Davies MA. Using Longitudinal Targeted Maximum Likelihood Estimation in Complex Settings with Dynamic Interventions. Statistics in Medicine. 2019; 38(24):4888-911. 

Ohlmeier C, Saum K-U, Galetzka W, Beier D, Gothe H. Epidemiology and health care utilization of patients suffering from Huntington's disease in Germany: real world evidence based on German claims data. BMC Neurology. 2019; 19(1):318. 

Milutinović M, Radovanović R, Šavikin K, Radenković S, Arvandi M, Pešić M, Kostić M, Miladinović B, Branković S, Kitić D. Chokeberry juice supplementation in type 2 diabetic patients – impact on health status. J Appl Biomed 2019; 17(4):218-24. 

Kerschberger B, Jobanputra K, Schomaker M, Kabore SM, Teck R, Mabhena E, Lukhele N, Rusch B, Boulle A, Ciglenecki I. Feasibility of antiretroviral therapy initiation under the treat-all policy under routine conditions: a prospective cohort study from Eswatini. Journal of the International AIDS Society. 2019; 22(10):e25401. 

Jesson J, Schomaker M, Malasteste K, Wati DK, Kariminia A, Sylla M, Kouadio K, Sawry S, Mubiana-Mbewe M, Ayaya S, Vreeman R, McGowan CC, Yotebieng M, Leroy V, Davies M-A, Ie DEAgcc. Stunting and growth velocity of adolescents with perinatally acquired HIV: differential evolution for males and females. A multiregional analysis from the IeDEA global paediatric collaboration. Journal of the International AIDS Society. 2019; 22(11):e25412. 

Gothe H, Rajsic S, Vukicevic D, Schoenfelder T, Jahn B, Geiger-Gritsch S, Brixner D, Popper N, Endel G, Siebert U. Algorithms to identify COPD in health systems with and without access to ICD coding: a systematic review. BMC health services research. 2019; 19(1):737. 

Fuchs E, Wolf S, Sroczynski G. Zervixkarzinom Prävention: Implementierung eines HPV-Screening-Tests in die Früherkennung eines Gebärmutterhalskrebses bei Frauen in Österreich. LBI-HTA Projektbericht Nr.: 121 Wien, Austria Ludwig Boltzmann Institut für Health Technology Assessment; 2019. 

Flatscher-Thöni M, Leiter AM, Winner H. Are Pain and Suffering Awards (Un-)Predictable? Evidence from Germany. DANUBE: Law, Economics and Social Issues Review. 2019; 10(3):199-219. 

Antony G, Fried A, Habimana K, Ostermann H. Aktiv und gesund altern in Österreich. Project Report. Wien, Österreich: 2019. 

Alex K, Benning F, Steigenberger C. Internationale Klausurwoche (BMBF): „Defining the value of medical interventions – Normative and empirical challenges“. Ethik in der Medizin. 2019; 32:107-10. 

Jahn B, Sroczynski G, Bundo M, Mühlberger N, Puntscher S, Todorovic J, Rochau U, Oberaigner W, Koffijberg H, Fischer T, Schiller-Fruehwirth I, Ofner D, Renner F, Jonas M, Hackl M, Ferlitsch M, Siebert U, Austrian Colorectal Cancer Screening Model G. Effectiveness, benefit harm and cost effectiveness of colorectal cancer screening in Austria. BMC Gastroenterol. 2019; 19(1):209. 

Schomaker M, Kühne F, Siebert U. Regarding: Effect Estimates in Randomized Trials and Observational Studies: Comparing Apples with Apples. American Journal of Epidemiology. 2019;189(1):77-8. doi: https://doi.org/10.1093/aje/kwz194.

Stella SF, Polanczyk C A, Arvandi M, Siebert U. Cost utility of fractional flow reserve-guided percutaneous coronary intervention in multivessel coronary artery disease in Brazil. International Journal for Quality in Health Care. 2019; 31(9):676-81. 

Borba HHL, Rochau U, Wiens A, Sroczynski G, Siebert U, Ferreira VL, Minowa E, Pontarolo R. Effectiveness and Cost-Effectiveness of Triple Therapy With Telaprevir and Boceprevir for Chronic Hepatitis C: A Decision Analysis From the Brazilian Public Health System Perspective. Value Halth Reg Issues. 2019; 20:95-102. 

Latimer NR, White IR, Abrams KR, Siebert U. Causal inference for long-term survival in randomised trials with treatment switching: Should re-censoring be applied when estimating counterfactual survival times? Statistical Methods in Medical Research 2019;28(8):2475-93. doi: 10.1177/0962280218780856.

Miksch F, Jahn B, Espinosa KJ, Chhatwal J, Siebert U, Popper N. Why should we apply ABM for decision analysis for infectious diseases?-An example for dengue interventions. PLosOne 2019;14(8):e0221564.

Ammenwerth E, Hoerbst A, Lannig S, Mueller G, Siebert U, Schnell-Inderst P. Effects of Adult Patient Portals on Patient Empowerment and Health-Related Outcomes: A Systematic Review. Stud Health Technol Inform 2019;264:1106-1110.

Jahn B, Todorovic J, Bundo M, Sroczynski G, Conrads-Frank A, Rochau U, Endel G, Wilbacher I, Malbaski N, Popper N, Chhatwal J, Greenberg D, Mauskopf J, Siebert U. Budget Impact Analysis of Cancer Screening: A Methodological Review. Appl Health Econ Health Policy. 2019;17(4):493-511.

Sommer I, Titscher V, Teufer B, Klerings I, Nußbaumer-Streit B, Szelag M, Affengruber L, Wagner G, Glechner A, Kien C, Ebenberger A, Schiller-Frühwirt I, Dorner TE, Siebenhofer A, Haditsch B, Bachler H, Siebert U, Gartlehner G. Evidenzbasierte Empfehlungen zur Überarbeitung der österreichischen Vorsorgeuntersuchung. Wiener Medizinische Wochenzeitschrift. 2019; 169(13-14):339-49. 

Latimer N, Abrams KR, Siebert U. Two-stage estimation to adjust for
treatment switching in randomised trials: a simulation study
investigating the use of inverse probability weighting instead of
re-censoring. BMC Medical Research Methodology 2019;19(1):69. doi:
10.1186/s12874-019-0709--9.

Rajsic S, Gothe H, Borba HH, Sroczynski G, Vujicic J, Toell T, Siebert
U. Economic burden of stroke: a systematic review on post-stroke care.
Eur J Health Econ 2019;20(1):107-134.

Hillemanns P, Friese K, Dannecker C, Klug S, Seifert U, Iftner T,
Hädicke J, Löning T, Horn L, Schmidt D, Ikenberg H, Steiner M, Freitag
U, Siebert U, Sroczynski G, Sauerbrei W, Beckmann MW, Gebhardt M,
Friedrich M, Münstedt K, Schneider A, Kaufmann A, Petry KU, Schäfer APA,
Pawlita M, Weis J, Mehnert A, Fehr M, Grimm C, Reich O, Arbyn M,
Kleijnen J, Wesselmann S, Nothacker M, Follmann M, Langer T, Jentschke
M. Prevention of Cervical Cancer: Guideline of the DGGG and the DKG (S3
Level, AWMF Register Number 015/027OL, December 2017) - Part 2 on
Triage, Treatment and Follow-up. Geburtshilfe Frauenheilkd.
2019;79(2):160-176. doi: 10.1055/a-0828-7722. Epub 2019 Feb 18.

Hillemanns P, Friese K, Dannecker C, Klug S, Seifert U, Iftner T,
Hädicke J, Löning T, Horn L, Schmidt D, Ikenberg H, Steiner M, Freitag
U, Siebert U, Sroczynski G, Sauerbrei W, Beckmann MW, Gebhardt M,
Friedrich M, Münstedt K, Schneider A, Kaufmann A, Petry KU, Schäfer APA,
Pawlita M, Weis J, Mehnert A, Fehr M, Grimm C, Reich O, Arbyn M,
Kleijnen J, Wesselmann S, Nothacker M, Follmann M, Langer T, Jentschke
M. Prevention of Cervical Cancer: Guideline of the DGGG and the DKG (S3
Level, AWMF Register Number 015/027OL, December 2017) - Part 1 with
Introduction, Screening and the Pathology of Cervical Dysplasia.
Geburtshilfe Frauenheilkd. 2019;79(2):148-159. doi: 10.1055/a-0818-5440.
Epub 2019 Feb 18.

Stella SF, Polanczyk CA, Arvandi M, Siebert U. Cost utility of
fractional flow reserve guided percutaneous coronary intervention in
multivessel coronary artery disease in Brazil. International Journal for
Quality in Health Care. 2018 [in press].

Leitinger M, Trinka E, Giovannini G, Zimmermann G, Florea G, Rohracher
A, Kalss G, Neuray C, Kreidenhuber R, Höfler J, Kuchukhidze G,
Granbichler C, Dobesberger J, Novak HF, Pilz G, Meletti S, Siebert U.
Epidemiology of status epilepticus in adults: a population-based study
on incidence, causes, and outcome. Epilepsia 2019;60(1):53-62.

Adarkwah CC, Jegan N, Heinzel-Gutenbrunner M, Kühne F, Siebert U, Popert
U, Donner-Banzhoff N, Kürwitz S. The Optimizing-Risk-Communication
(OptRisk) randomized trial - impact of decision-aid-based consultation
on adherence and perception of cardiovascular risk. Patient Preference
and Adherence 2019:13;441–452.

Loeb S, Curnyn C, Walter D, Fagerlin A, Siebert U, Mühlberger N, Braithwaite RS, Schwartz MD, Lepor H, Sedlander E. Health state utilities among contemporary prostate cancer patients on active surveillance. Transl Androl Urol. 2018;7(2):197-202. doi: 10.21037/tau.2017.03.80

Stühlinger V. Solidarität und Ethische Entscheidungsfindung im Gesundheitswesen, in Voithofer C, Ganner M. RTF Tagungsband, pp. 176-193, Innsbruck University Press, 2018.

Siebert U, Hallsson LR. To stop or not to stop: a value of information
view. Eur J Epidemiol. 2018;33(9):785-87. doi: 10.1007/s10654-018-0432-6.

Stella SF, Polanczyk CA, Arvandi M, Siebert U. Cost utility of
fractional flow reserve guided percutaneous coronary intervention in
multivessel coronary artery disease in Brazil. International Journal for
Quality in Health Care. 2018. doi: 10.1093/intqhc/mzy240. [Epub ahead of
print].

Völzke H; Erlund I; Hubalewska-Dydejczyk A; Ittermann T; Peeters RP;
Rayman M; Buchberger M; Siebert U; Thuesen BH; Zimmermann MB; Grunert S; Lazarus JH. How Do We Improve the Impact of Iodine Deficiency Disorders
Prevention in Europe and Beyond? European Thyroid Journal.
2018;7(4):193-200.

Kristensen FB, Husereau D, Augustovski F, Berger ML, Bond K, Booth A,
Bridges JFP,  Drummond M, Grimshaw J, Hui M, Ijzerman MJ, Jonsson E,
Ollendorf DA, Rüther A, Siebert U, Sharma J, Wailoo A. Identifying the
Need for Good Practices in Health Technology Assessment: Summary of the
ISPOR HTA Council Working Group Report on Good Practices in HTA. Value
in Health [in press].

Veličković VM, Borisenko O, Svensson M, Spelman T, Siebert U. Congenital heart defect repair with ADAPT tissue engineered pericardium scaffold: An early-stage health economic model. PLoS ONE 2018;13(9):e0204643.

Leitinger M, Trinka E, Giovannini G, Zimmermann G, Florea G, Rohracher 
A, Kalss G, Neuray C, Kreidenhuber R, Höfler J, Kuchukhidze G, 
Granbichler C, Dobesberger J, Novak HF, Pilz G, Meletti S, Siebert U. 
Epidemiology of status epilepticus in adults: a population-based study 
on incidence, causes, and outcome. Epilepsia 2018 [in press].

Veličković VM, Rochau U, Conrads-Frank A, Kee F, Blankenberg S, Siebert U. Systematic assessment of decision-analytic models evaluating diagnostic tests for acute myocardial infarction based on cardiac troponin assays, Expert Review of Pharmacoeconomics & Outcomes Research 2018 Sep 6:1-22. doi: 10.1080/14737167.2018.1512857. [Epub ahead of print].

Arvandi M, Strasser B, Volaklis K, Ladwig KH, Grill E, Gothe RM, Horsch A, Laxy M, Siebert U, Peters A, Thorand B, Meisinger C. Mediator effect of balance problems on association between grip strength and falls in older adults: Results from the KORA-Age Study. Gerontology and Geriatric Medicine 2018;4:2333721418760122. doi: 10.1177/2333721418760122. eCollection 2018 Jan-Dec.

Richter AK, Klimek L, Merk HF, Mülleneisen N, Renz H, Wehrmann W, Werfel T, Hamelmann E, Siebert U, Sroczynski G, Wasem J, Biermann-Stallwitz J. Impact of increasing treatment rates on cost-effectiveness of subcutaneous immunotherapy (SCIT) in respiratory allergy: a decision analytic modelling approach. Eur J Health Econ. 2018 [in press]. doi: 10.1007/s10198-018-0970-6. [Epub ahead of print].

Widschwendter M, Jones A, Evans I, Reisel D, Dillner J, Sundström K, Steyerberg EW, Vergouwe Y, Wegwarth O, Rebitschek FG, Siebert U, Sroczynski G, de Beaufort ID, Bolt I, Cibula D, Zikan M, Bjørge L, Colombo N, Harbeck N, Dudbridge F, Tasse A-M, Knoppers BM, Joly Y, Teschendorff AE, Pashayan N, FORECEE (4C) Consortium. Epigenome-based cancer risk prediction: rationale, opportunities and challenges. Nature Reviews Clinical Oncology 2018;15(5):292-309. doi: 10.1038/nrclinonc.2018.30. Epub 2018 Feb 27. Review. [Epub ahead of print].

Seidl A, Danner M, Wagner CJ, Sandmann FG, Sroczynski G, Stürzlinger H, Zsifkovits J, Schwalm A, Lhachimi SK, Siebert U, Gerber-Grote A. Estimation of Input Costs for a Markov Model in a German Health Economic Evaluation of Newer Antidepressants. MDM Policy & Practice 2018;1-11.

Schnell-Inderst P, Hunger T, Conrads-Frank A, Arvandi M, Siebert U. Ten recommendations for assessing the comparative effectiveness of therapeutic medical devices: A targeted review and adaptation. J Clin Epidemiol. 2018;94:97-113.

Schnell-Inderst P, Hunger T, Conrads-Frank A, Arvandi M, Siebert U. Recommendations for primary studies evaluating therapeutic medical devices were identified and systematically reported through reviewing existing guidance. J Clin Epidemiol. 2018;94:46-58.

Christensen KD, Uhlmann WR, Roberts JS, Linnenbringer E, Whitehouse PJ, Royal CDM, Obisesan TO, Cupples LA, Butson MB, Fasaye GA, Hiraki S, Chen CA, Siebert U, Cook-Deegan R, Green RC. A randomized controlled trial of disclosing Genetic risk information for Alzheimer's disease via telephone. Genetics in Medicine 2018:20(1):132-141.

Schulc E, Gothe R, Tufan I, Them C, Mueller G. Self-Reported Questionnaire of Functional Health (Q-FH2) of Home-Dwelling Elderly People Living in Austria – Based on the Patient Questionnaire of the Standardized Assessment of Elderly People in Primary Care (STEP). Journal of Nursing Measurement 2017;25(2):238-256. doi: 10.1891/1061-3749.25.2.238.

Semsroth S, Matteucci Gothe R, Raith YR, de Brabandere K, Hanspeter E, Kilo J, Kofler M, Müller L, Ruttman-Ulmer E, Grimm M. Comparison of two minimally invasive techniques and median sternotomy in aortic valve replacement. Ann Thorac Surg 2017;104(3):877-883. doi: 10.1016/j.athoracsur.2017.01.095.

Stühlinger V. (gemeinsam mit: Schnell-Inderst P., Siebert U.), Health Technology Assessment (HTA) and its Relevance to Cross-border Healthcare (CBC) in Europe, in André Den Exter (Ed) Cross-border health Care and European Union Law, pp 167-190, e-book - published 2017; ISBN: 978-90-9030461-8.

Perleth M, Schnell-Inderst P, Rüther A., Raatz H, Kolominsky-Rabas P, Panteli D, Siebert U, Berndt N, Wahlster P. Das Curriculum Health Technology Assessment (HTA), Version 2.0, GMS Health Technology Assessment 2017;13:Doc03:1-10.

Hörster L, Schlenk RF, Stadler M, Gabriel M, Thol F, Schildmann J, Vollmann J, Rochau U, Sroczynski G, Wasem J, Ganser A, Port M, Neumann A. Cost-effectiveness of methods in personalized medicine. Results of a decision-analytic model in patients with acute myeloid leukemia with normal karyotype. Leuk Res. 2017; 62:84-90.

Loeb S, Zhou Q, Siebert U, Rochau U, Jahn B, Mühlberger N, Carter HB, Lepor H, Braithwaite RS. Active Surveillance Versus Watchful Waiting for Localized Prostate Cancer: A Model to Inform Decisions.Eur Urol. 2017 Dec;72(6):899-907.

Jahn B, Arvandi M, Rochau U, Fiegl H, Goebel G, Marth C, Siebert U. Development of a novel prognostic score for breast cancer patients using mRNA expression of CHAC. BMC Cancer 2017;6(7):563-574.

Adarkwah CC, Jegan N, Kuerwitz S, Heinzel-Gutenbrunner M, Kuehne F, Siebert U, Popert U, Donner-Banzhoff N. [Cardiovascular risk assessment in younger patients: Implications of different risk representation on risk perception and decisional conflict]. Z Allg Med 2017;93(9):353-359.

Jahn B, Rochau U, Kurzthaler C, Hubalek M, Miksad R, Sorczynski G, Paulden M, Bundo M, Stenehjem D, Brixner D, Krahn M, Siebert U.Personalized treatment of women with early breast cancer: a risk-group specific cost-effectiveness analysis of adjuvant chemotherapy accounting for companion prognostic tests OncotypeDX and Adjuvant!Online. BMC Cancer 2017;16;17(1):685 [in press].

Schiller-Fruehwirth I, Jahn B, Einzinger P, Zauner G, Urach C, Siebert U. The Long-Term Effectiveness and Cost Effectiveness of Organized versus Opportunistic Screening for Breast Cancer in Austria. Value Health. 2017;20(8):1048-1057.

Oberaigner W, Geiger-Gritsch S, Edlinger M, Daniaux M, Knapp R, Hubalek M, Siebert U, Marth C, Buchberger W. Reduction in advanced breast cancer after introduction of a mammography screening program in Tyrol/Austria. Breast. 2017;33:178-182.

Mühlberger N, Boskovic K, Krahn MD, Bremner KE, Oberaigner W, Klocker H, Horninger W, Sroczynski G, Siebert U. Benefits and Harms of Prostate Cancer Screening - Predictions of the ONCOTYROL Prostate Cancer Outcome and Policy Model. BMC Public Health 2017;17(1):596, doi: 10.1186/s12889-017-4439-9.[Open Access: https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-017-4439-9].

Geiger-Gritsch S, Buchberger W, Knapp R, Daniaux M, Tabar L, Marth, Hubalek M, Edlinger M, Siebert U, Oberaigner W. Reduction in advanced breast cancer and changes in breast cancer therapy after introduction of a mammography screening program in Tyrol/Austria. The Breast 2017;33:178-182. doi: 10.1016/j.breast.2017.04.002.

Schiller-Frühwirth IC, Jahn B, Arvandi M, Siebert U. Cost-effectiveness models in breast cancer screening in the general population: A systematic review. Appl Health Econ Health Policy 2017;15(3): 333-351.

Di Paolo A, Sarkozy F, Ryll B, Siebert U. Personalized medicine in Europe: not yet personal enough? BMC Health Services Research 2017;17(1):289 [in press].

Bose-O'Reilly S, Bernaudat L, Siebert U, Roider G, Nowak D, Drasch G. Signs and symptoms of mercury exposed gold miners. International Journal of Occupational Medicine and Environmental Health 2017; 30(2):249-269.

Loeb S, Curnyn C, Walter D, Fagerlin A, Siebert U, Mühlberger N, Braithwaite RS, Schwartz MD, Lepor H, Sedlander E. Health state utilities among contemporary prostate cancer patients on active surveillance. Transl Androl Urol 2017 [in press].

Schulc E, Gothe R, Tufan I, Them C, Mueller G. Self-Reported Questionnaire of Functional Health (Q-FH2) of Home-Dwelling Elderly People Living in Austria – Based on the Patient Questionnaire of the Standardized Assessment of Elderly People in Primary Care (STEP). Journal of Nursing Measurement 2017 [in press].

Semsroth S, Matteucci Gothe R, Raith YR, de Brabandere K, Hanspeter E, Kilo J, Kofler M, Müller L, Ruttman-Ulmer E, Grimm M. Comparison of two minimally invasive techniques and median sternotomy in aortic valve replacement. The Annals of Thoracic Surgery 2017 [in press].

Czarnecka-Kujawa K, Rochau U, Siebert U, Atenafu E, Darling G, Waddell TK, De Perrot M, Pierre A, Cypel M, Keshavjee S, Yasufuku K. Cost-Effectiveness of Mediastinal Lymph Node Staging in NSCLC. The Journal of Thoracic and Cardiovascular Surgery 2017 [in press].

Schnell-Inderst P, Iglesias CP, Arvandi M, Ciani O, Matteucci Gothe R, Peters J, Blom AW, Taylor RS, Sculpher M, Siebert U. Synthesis of RCT and observational data: a bias-adjusted evidence synthesis of total hip replacement. Health Econ. 2017;26(Suppl 1):46-69.

Arvandi M, Strasser B, Meisinger C, Volaklis K, Gothe RM, Siebert U, Ladwig KH, Grill E, Horsch A, Laxy M, Peters A, Thorand B. Gender differences in the association between grip strength and mortality in older adults: results from the KORA-age study. BMC Geriatrics 2016;16(1):201 [epub]

Adarkwah CC, Jegan N, Heinzel-Gutenbrunner M, Kühne F, Siebert U, Popert U, Donner-Banzhoff N, Kürwitz S. Time-to-event versus ten-year-absolute-risk in cardiovascular risk prevention - does it make a difference? Results from the Optimizing-Risk-Communication (OptRisk) randomized-controlled trial. BMC Med Inform Decis Mak. 2016;16(1):152.

Hunger T, Schnell-Inderst P, Sahakyan N, Siebert U. Using expert opinionin health technology assessment: a guideline review. InternationalJournal of Technology Assessment in Health Care 2016;1-9, 2016 Aug 9.

Dams J, Balzer-Geldsetzer M, Siebert U, Deuschl G, Schuepbach WM, Krack P, Timmermann , Schnitzler A, Reese JP, Dodel R, EARLYSTIM-investigators. Cost-effectiveness of neurostimulation in Parkinson's disease with early motor complications. Movement Disorders 2016;31(8):1183-91.

Bose-O'Reilly S, Schierl R, Nowak D, Siebert U, Jossep FW, Fradico TO, Yuyun I Ir. A preliminary study on health effects in villagers exposed to mercury in a small-scale artisanal gold mining area in Indonesia. Environmental Research 2016; 149:274-81.

Luzak A; Schnell-Inderst P; Buhn S; Mayer-Zitarosa A; Siebert U. Clinical effectiveness of cancer screening biomarker tests offered as self-pay health service: a systematic review. European Journal of Public Health 2016; 26(3):498-505.

Ha E, Basu N, Bose-O'Reilly S, Dórea JG, McSorley E, Sakamoto M, Chan HM. Current progress on understanding the impact of mercury on humanhealth. Environ Res. 2016; [Epub ahead of print].

Jahn B, Rochau U, Kurzthaler C, Paulden M, Kluibenschädl M, Arvandi M, Kühne F, Goehler A, Krahn M, Siebert U. Lessons learned from a cross-model validation between a discrete event simulation model and a cohort state-transition model for personalized breast cancer treatment. Medical Decision Making 2016;36(3):375-90.

Gschmeidler B, Flatscher-Thöni M, Knitel-Grabher E. Genetics in the medical and psychosocial practice: on the role of value hierarchies in counselling, Journal of Public Health 2016 [epub 16 March 2016].

Leoni-Scheiber C, Matteucci Gothe R, Müller-Staub M. Die Einstellung deutschsprachiger Pflegefachpersonen gegenüber dem «Advanced Nursing Process» vor und nach einer Bildungsintervention – Quasi-experimentelle Interventionsstudie. Pflege 2016; 29(1):33-42.

Ultsch B, Damm O, Beutels P, Bilcke J, Bruggenjurgen B, Gerber-Grote A, Greiner W, Hanquet G, Hutubessy R, Jit M, Knol M, von Kries R, Kuhlmann A, Levy-Bruhl D, Perleth M, Postma M, Salo H, Siebert U, Wasem J, Wichmann O. Methods for Health Economic Evaluation of Vaccines and Immunization Decision Frameworks: A Consensus Framework from a European Vaccine Economics Community. Pharmacoeconomics 2016;34(3):227-44.

Willenbacher E, Weger R, Rochau U, Siebert U, Willenbacher W, on behalf of the Austrian Myeloma Registry (AMR). Real-world use of 3rd line therapy for Multiple Myeloma in Austria: An Austrian Myeloma Registry (AMR) analysis of the therapeutic landscape and clinical outcomes prior to the use of next generation myeloma therapeutics. PLoS One 2016; DOI: 10.1371.

Leichtfried V, Basic D, Burtscher M, Gothe RM, Siebert U, Schobersberger W. Diagnosis and prediction of the occurrence of acute mountain sickness measuring oxygen saturation--independent of absolute altitude?. Sleep & Breathing 2016;20(1):435-42.

Völzke H, Caron P, Dahl L, de Castro JJ, Erlund I, Gaberšček S, Gunnarsdottir I, Hubalewska-Dydejczyk A, Ittermann T, Ivanova L, Karanfilski B, Khattak RM, Kusić Z, Laurberg P, Lazarus JH, Markou KB, Moreno-Reyes R, Nagy EV, Peeters RP, Pīrāgs V, Podoba J, Rayman MP, Rochau U, Siebert U, Smyth PP, Thuesen BH, Troen A, Vila L, Vitti P, Zamrazil V, Zimmermann MB, John Lazarus, for the Iodine Global Network (IGN) West Central Europe group. Ensuring effective prevention of iodine-deficiency disorders. Thyroid 2016;26(2):189-96.

Stenehjem D, Bellows BK, Yager KM, Jones J, Kaldate R, Siebert U, Brixner D. Cost-Utility of a Prognostic Test Guiding Adjuvant Chemotherapy Decisions in Early-Stage Non-Small Cell Lung Cancer. The Oncologist 2016;21(2):196-204. 

Latimer NR, Henshall C, Siebert U, Bell H. Treatment Switching: statistical and decision-making challenges and approaches. International Journal of Technology Assessment in Health Care 2016;32(3):160–6.

Rochau U, Schwarzer R, Jahn B, Sroczynski G, Kluibenschaedl M, Wolf D, Radich J, Brixner D, Gastl G, Siebert U. Systematic assessment of decision-analytic models for chronic myeloid leukemia. Appl Health Econ Health Policy 2014;12(2):103-15.

Obach D, Deuffic-Burban S, Esmat G, Anwar WA, Dewedar S, Canva V, Cousien A, Doss W, Mostafa A, Pol S, Buti M, Siebert U, Fontanet A, Mohamed MK, Yazdanpanah Y. Effectiveness and cost-effectiveness of immediate versus delayed treatment of hepatitis C virus-infected patients in a country with limited resources: the case of Egypt. Clin Infect Dis 2014;58(8):1064-71.

Blatt, CR, Storb, B, Mühlberger, N, Farias, MR, Siebert, U. Chronic Hepatitis C treatment for genotype 2 or 3 in Brazil: cost effectiveness analysis of peginterferon plus ribavirin as first choice treatment. Brazilian Journal of Pharmaceutical Sciences 2014; 50(2):345-352.

Siebert U. Arvandi M. M Gothe R. Bornschein B. Eccleston D. L Walters D. Rankin J. De Bruyne B. F Fearon W. H Pijls N. Harper R. Improving the Quality of Percutaneous Revascularisation in Patients with Multivessel Disease in Australia: Cost-Effectiveness, Public Health Implications, and Budget Impact of FFR-Guided PCI. Heart, Lung & Circulation 2014;23(6):527-33.

Zeller T, Hughes M, Tuovinen T, Schillert A, Conrads-Frank A, den Ruijter H, Schnabel RB, Kee F, Salomaa V, Siebert U, Thorand B, Ziegler A, Breek H, Pasterkamp G, Kuulasmaa K, Koenig W, Blankenberg S on behalf of the BiomarCaRE consortium. BiomarCaRE - rationale and design of the European BiomarCaRE Project including 300,000 participants from 13 European countries. Eur J Epidemiol. 2014;29(10):777-90.

Rochau U, Sroczynski G, Wolf D, Schmidt S, Jahn B, Saverno K, Brixner D, Radich J, Siebert U. Medical Decision Analysis for the First-line Therapy of Chronic Myeloid Leukemia. Leukemia and Lymphoma 2014;55(8):1758-67.

Steckling N, Bose-O'Reilly B, Pinheiro P, Plass D, Shoko D, Drasch G, Bernaudat L, Siebert U, Hornberg C. The burden of chronic mercury intoxication in artisanal small-scale gold mining in Zimbabwe: data availability and preliminary estimates. Environmental Health 2014;13:111.

Leichtfried V, Matteucci Gothe R, Kantner-Rumplmair W, Mair-Raggautz M, Bartenbach C, Guggenbichler H, Gehmacher D, Jonas L, Aigner M, Winkler D, Schobersberger W. Short-term effects of bright light therapy in adults with chronic nonspecific back pain: a randomized controlled trial. Pain Med. 2014;15(12):2003-12.

Schusterschitz C, Flatscher-Thöni M, Leiter-Scheiring A, Geser W. Building a committed volunteer workforce – Are it variables at the experience stage that count? Journal of Community and Applied Social Psychology 2014;24(5):422-38.

Stühlinger V, Hackl M. Research Ethics Committees in the Field of Health-Related Human Research – A European Perspective and the Case of Austria, European Journal of Health Law 2014;21(4):, 387-400.

Flatscher-Thöni M, Leiter-Scheiring A, Winner H. Schmerzensgeld in Österreich: Eine quantitative Betrachtung, Journal für Rechtspolitik 2014;22:85-9. 

Voithofer C, Flatscher-Thöni M. VfGH vereinfacht Zugang zur Fortpflanzungsmedizin. Was passiert, wenn nichts passiert? Interdisziplinäre Zeitschrift für Familienrecht 2014;9(2):54-6.

Flatscher-Thöni M, Voithofer C. Stellungnahme zum Entwurf eines Bundesgesetzes, mit dem das Fortpflanzungsmedizingesetz, das Allgemeine Bürgerliche Gesetzbuch und das Gentechnikgesetz geändert werden  Fortpflanzungsmedizinrechts-Änderungsgesetz 2015 – FMedRÄG 2015) - BMJ-Z3.509/0010-I 1/2014 (77/ME), November 2014. [Opinion paper].

Stühlinger V, News from the European Association of Health Law, Bioethical Voices. Newsletter of the UNESCO Chair in Bioethics, September 2014:4. [Letter].

Flatscher-Thöni M, Voithofer C. Austrian Constitutional Court: Recent decision on access to reproductive medicine, Bioethical Voices. Newsletter of the UNESCO Chair in Bioethics, December 2014:5. [Letter].

Zechmeister-Koss I, Schnell-Inderst P, Zauner G. Appropriate Evidence Sources for Populating Decision Analytic Models within Health Technology Assessment (HTA): A Systematic Review of HTA Manuals and Health Economic Guidelines. Medical Decision Making 2014 [epub ahead of print].

Rautenberg T, Siebert U, Arnold D, Bennouna J, Kubicka S, Walzer S, Ngoh C. Economic outcomes of sequences which include monoclonal antibodies against vascular endothelial growth factor and/or epidermal growth factor receptor for the treatment of unresectable metastatic colorectal cancer. J Med Econ 2014;17(2):99-110.

Hunger T, Schnell-Inderst P, Hintringer K, Schwarzer R, Seifert-Klauss V, Gothe H, Wasem J, Siebert U. Health technology assessment of utilization, practice and ethical issues of self-pay services in the German ambulatory health care setting. Int J Public Health 2014;59(1):175-87.

Saverno K, Gothe H, Schuessel K, Biskupiak J, Schulz M, Siebert U, Brixner D. Consideration of international generic distribution policies on patient outcomes in the United States and Germany. Pharmazie 2014;69(3):3.

Rochau U, Schwarzer R, Jahn B, Sroczynski G, Kluibenschaedl M, Wolf D, Radich J, Brixner D, Gastl G, Siebert U. Systematic Assessment of Decision-Analytic Models for Chronic Myeloid Leukemia. Appl Health Econ Health Policy 2014:103-115.

Rochau U, Sroczynski G, Wolf D, Schmidt S, Conrads-Frank A, Jahn B, Saverno K, Brixner D, Radich J, Gastl G, Siebert U. Medical decision analysis for first-line therapy of chronic myeloid leukemia. Leuk Lymphoma 2014;55(8):1758-67.

Siebert U, Rochau U, Claxton K. When is enough evidence enough? – Using systematic decision analysis and value-of-information analysis to determine the need for further evidence. Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen 2013;107(9–10):575-584.

Siebert U, Arvandi M, R MG, Bornschein B, Eccleston D, D LW, Rankin J, De Bruyne B, W FF, N HP, Harper R. Improving the Quality of Percutaneous Revascularisation in Patients with Multivessel Disease in Australia: Cost-Effectiveness, Public Health Implications, and Budget Impact of FFR-Guided PCI. Heart Lung Circ 2014:527-533.

Nolte JE, Neumann T, Manne JM, Lo J, Neumann A, Mostardt S, Abbara S, Hoffmann U, Brady TJ, Wasem J, Grinspoon SK, Gazelle GS, Goehler A. Cost-effectiveness analysis of coronary artery disease screening in HIV-infected men. Eur J Prev Cardiol 2014;21(8):972-9.

Dams J, Klotsche J, Bornschein B, Reese JP, Balzer-Geldsetzer M, Winter Y, Schrag A, Siderowf A, Oertel WH, Deuschl G, Siebert U, Dodel R. Mapping the EQ-5D index by UPDRS and PDQ-8 in patients with Parkinson's disease. Health and Quality of Life Outcomes 2013;11(1):35.

Weinberger B, Schirmer M, Matteucci Gothe R, Siebert U, Fuchs D, Grubeck-Loebenstein B. Recall Responses to Tetanus and Diphtheria Vaccination Are Frequently Insufficient in Elderly Persons. PLoS ONE 2013;8(12):e82967.

Saverno K, Gothe H, Schuessel K, Biskupiak J, Schulz M, Siebert U, Brixner D. Consideration of international generic distribution policies on patient outcomes in the United States and Germany [accepted]. Pharmazie 2013:1-3.

Siebert U, Rochau U, Claxton K. When is enough evidence enough? – Using systematic decision analysis and value-of-information analysis to determine the need for further evidence. Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen 2013;107(9–10):575-584.

Haider T, Gunga HC, Matteucci‐Gothe R, Sottara E, Griesmacher A, Belavý DL, Felsenberg D, Werner A, Schobersberger W. Effects of long‐term head‐down‐tilt bed rest and different training regimes on the coagulation system of healthy men. Physiological Reports 2013;1(6).

Institute for Quality and Efficiency in Health Care (IQWIG). Health economic evaluation of venlafaxine, duloxetine, bupropion, and mirtazapine compared to further prescribable pharmaceutical treatments. Executive Summary. IQWiG Reports – Commission No. G09-01, IQWiG-Report – Nr. 190. Cologne, Germany: Institute for Quality and Efficiency in Health Care, 2013;1-626.

Gschmeidler B, Flatscher-Thöni M. Ethical and Professional Challenges of Genetic Counseling - the Case of Austria. Journal of Genetic Counseling, 2013:22(6): 741-52.

Flatscher-Thöni M, Leiter A, Winner H. Pricing Damages for Pain and Suffering in Court: The Impact of the Valuation Method. Journal of Empirical Legal Studies 2013;10(1):104–19.

Stühlinger V, Schwamberger H. Forschung am Menschen im nichtärztlichen Bereich – Vorlagepflichten und Prüfmöglichkeiten durch Ethikkommissionen, Recht der Medizin (RdM) 2013; Issue 06, 146:283-9.

Sroczynski G, Siebert U. Viral hepatitis: Cost-effectiveness of direct-acting antivirals for chronic hepatitis C. Nat Rev Gastroenterol Hepatol 2013;10(10):572-574.

Tanios N, Wagner M, Tony M, Baltussen R, van Til J, Rindress D, Kind P, Goetghebeur MM, and the International Task Force on Decision Criteria. Which criteria are considered in healthcare decisions? Insights from an international survey of policy and clinical decision makers. International Journal of Technology Assessment in Health Care 2013;29(4):456-65.

Husereau D, Drummond M, Petrou S, Carswell C, Moher D, Greenberg D, Augustovski F, Briggs AH, Mauskopf J, Loder E. Consolidated Health Economic Evaluation Reporting Standards (CHEERS)-Explanation and Elaboration: A Report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force. Value Health 2013;16(2):231-250.

Sulz MC, Siebert U, Arvandi M, Gothe RM, Wurm J, von Kanel R, Vavricka SR, Meyenberger C, Sagmeister M. Predictors for hospitalization and outpatient visits in patients with inflammatory bowel disease: results from the Swiss Inflammatory Bowel Disease Cohort Study. Eur J Gastroenterol Hepatol 2013 25(7):790-797.

Siebert U, Wurm J, Matteucci-Gothe R, Arvandi M, Vavricka S, von Kaenel R, Begre S, Sulz M, Meyenberger C, Sagmeister M, Group SICS. Predictors of Temporary and Permanent Work Disability in Patients with Inflammatory Bowel Disease Results of the Swiss Inflammatory Bowel Disease Cohort Study. Inflammatory Bowel Diseases 2013;19(4):847-855.

Dams J, Klotsche J, Bornschein B, Reese JP, Balzer-Geldsetzer M, Winter Y, Schrag A, Siderowf A, Oertel WH, Deuschl G, Siebert U, Dodel R. Mapping the EQ-5D index by UPDRS and PDQ-8 in patients with Parkinson's disease. Health and Quality of Life Outcomes 2013;11(1):35.

Strasser B, Siebert U, Schobersberger W. Effects of resistance training on respiratory function in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. Sleep Breath 2013;17(1):217-26.

Dams J, Siebert U, Bornschein B, Volksmann J, Deuschl G, Oertel W, Dodel R, Reese JP. Cost-Effectiveness of Deep Brain Stimulation in Patients with Parkinson’s Disease. Mov Disord 2013 28(6):763-71.

Stollenwerk B, Gandjour A, Luengen M, Siebert U. Accounting for increased non-target-disease-specific mortality in decision-analytic screening models for economic evaluation. European Journal of Health Economics 2013 14(6):1035-48.

Froeschl B, Bornschein B, Brunner-Ziegler S, Conrads-Frank A, Eisenmann A, Gartlehner G, Grillich L, Kaminski A, Muehlberger N, Pertl D, Schnell-Inderst P, Sroczynski G, Siebert U, Thaler K, Wild C, Wurm J, Zechmeister I, Zsifkovits J, Horvath K, Pueringer U, Grouven U, Kurth T, Luehmann D, Swart E, Neumann A, Landauer R. Methodenhandbuch für Health Technology Assessment Version 1.2012. Eine Kooperation von Donau-Universität Krems (DUK), EBM Review Center Graz, Gesundheit Österreich GmbH (GÖG), Ludwig Boltzmann Institut für HTA (LBI-HTA) und Privater Universität für Gesundheitswissenschaften, Medizinische Informatik und Technik (UMIT). Wien, Österreich: Im Auftrag des Bundesministeriums für Gesundheit, 2012;1-425.

Online abrufbar: http://www.goeg.at/

Dimai HP, Redlich K, Peretz M, Borgstrom F, Siebert U, Mahlich J. Economic burden of osteoporotic fractures in Austria. Health Econ Rev 2012;2(1):12.

Siebert U. [Transparent Decisions in Public Health Using Systematic Decision Analysis]. [German]. In: Schwartz FW, Badura B, Busse R, Leidl R, Raspe H, Siegrist J, Walter U (eds.): [The Public Health Book. Health and Health Care]. 3rd ed. Urban & Fischer: Munich, 2012.

Deuffic-Burban S, Deltenre P, Buti M, Stroffolini T, Parkes J, Muehlberger N, Siebert U, Moreno C, Hatzakis A, Rosenberg W, Zeuzem S, Mathurin P. Predicted Effects of Treatment for HCV Infection Vary Among European Countries. Gastroenterology 2012;143:974–85. 

Caro JJ, Briggs AH, Siebert U, Kuntz KM, on Behalf of the ISPOR-SMDM Modeling Good Research Practices Task Force. Modeling Good Research Practices - Overview: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force -1. Value in Health 2012; 15:796-803.

Caro JJ, Briggs AH, Siebert U, Kuntz KM, on Behalf of the ISPOR-SMDM Modeling Good Research Practices Task Force. Modeling Good Research Practices - Overview: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force -1. Medical Decision Making 2012; 32(5): 667-677.

Siebert U, Alagoz O, Bayoumi AM, Jahn B, Owens DK, Cohen DJ, Kuntz KM. State-Transition Modeling: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force -3. Value in Health 2012; 15: 812-820.

Siebert U, Alagoz O, Bayoumi AM, Jahn B, Owens DK, Cohen DJ, Kuntz KM. State-Transition Modeling: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force -3. Medical Decision Making 2012; 32(5):690-700.

Verhoef TI, Redekop WK, van Schie RM, Bayat S, Daly AK, Geitona M, Haschke Becher E, Hughes DA, Kamali F, Levin LA, Manolopoulos VG, Pirmohamed M, Siebert U, Stingl JC, Wadelius M, de Boer A, Maitland-van der Zee AH. Cost-effectiveness of pharmacogenetics in anticoagulation: international differences in healthcare systems and costs. Pharmacogenomics 2012;13(12):1405-17.

Saverno, K., Stenehjem, D., et al. (2012). Application of Decision-Analytic Models in Personalized Medicine for CML Treatment Decisions Made by Payers, Providers, and Patients. Journal of Managed Care Pharmacy 18(6): 457-63.

Blatt C, Bernardo N, Rosa JA, Bagatini F, Alexandre R, Balbinotto Neto G, Siebert U, Rocha Farias M. An Estimate of the Cost of Hepatitis C Treatment for the Brazilian Health System. Value in Health Regional Issues 2012;1(2):129-135.

Steckling N, Boese-O'Reilly S, Pinheiro P, Plass D, Shoko D, Siebert U, Hornberg C. The burden of chronic mercury intoxication attributable to mercury use in artisanal small-scale gold mining in Zimbabwe. The Lancet 2012 [accepted].

Siebert U, Alagoz O, Bayoumi AM, Jahn B, Owens DK, Cohen DJ, Kuntz KM. State-Transition Modeling: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-3. Value in Health 2012;15:812-20. 

Drummond M, Neumann P, Jönsson B, Luce B, Schwartz JS, Siebert U, Sullivan SD. Can we reliably benchmark health technology assessment organizations? International Journal of Technology Assessment in Health Care 2012;28(2):159-65.

Bouchaud O, Muehlberger N, Parola P, Calleri G, Matteelli A, Peyerl-Hoffmann G, Méchai F, Gautret P, Clerinx J, Kremsner PG, Jelinek T, Kaiser A, Beltrame A, Schmid M, Kern P, Probst M, Bartoloni A, Weinke T, Grobusch MP. Therapy of uncomplicated falciparum malaria in Europe: MALTHER - a prospective observational multicentre study. Malaria Journal 2012;11:212.

Faulkner E, Annemans L, Garrison L, Helfand M, Holtdorf AP, Hornberger J, Hughes D, Li T, Malone D, Payne K, Siebert U, Towse A, Veenstra D, Watkins J. for Personalized Medicine Development and Reimbursement Working Group. Challenges in the Development and Reimbursement of Personalized Medicine—Payer and Manufacturer Perspectives and Implications for Health Economics and Outcomes Research: A Report of the ISPOR Personalized Medicine Special Interest Group. Value in Health 2012;15(8):1162-71.

Kretzschmar M, Mangen MJ, Pinheiro P, Jahn B, Fevre EM, Longhi S, Lai T, Havelaar AH, Stein C, Cassini A, Kramarz P. New methodology for estimating the burden of infectious diseases in Europe. PLoS Med 2012;9(4):e1001205.

Luce BR, Drummond MF, Dubois RW, Neumann PJ, Joensson B, Siebert U, Schwartz JS. Principles for planning and conducting comparative effectiveness research. Journal of Comparative Effectiveness Research 2012;1(5):431-40.

Caro JJ, Briggs AH, Siebert U, Kuntz KM, Force obotI-SMGRPT. Modeling Good Research Practices - Overview: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force -1. Medical Decision Making 2012;32(5):667-77.

Dimai HP, Redlich K, Schneider H, Siebert U, Vierstein H, Mahlich J. [Direct and Indirect Costs of Fractures due to Osteoporosis in Austria]. Gesundheitswesen 2012;74(10):e90-e98.

Siebert U, Rochau U. Personalisierte Krebstherapie. PharmacoEconomics 2012;10:87-104.

Strasser B, Arvandi M, Siebert U. Resistance training, visceral obesity and inflammatory response: a review of the evidence. Obes Rev 2012;13(7):578-591.

Oberaigner W, Siebert U, Horninger W, Klocker H, Bektic J, Schafer G, Frauscher F, Schennach H, Bartsch G. Prostate-specific antigen testing in Tyrol, Austria: prostate cancer mortality reduction was supported by an update with mortality data up to 2008. Int J Public Health 2012;57(1):57-62.

Krobot KJ, Wagner A, Siebert U. Risk factor levels, risk factor combinations, and residual coronary risk: population-based estimates for secondary prevention patients using statins. Eur J Cardiovasc Prev Rehabil 2012;19(1):109-17.

Oberaigner W, Minicozzi P, Bielska-Lasota M, Allemani C, De Angelis R, Mangone L, Sant M, EUROCARE Working Group. Survival for Ovarian Cancer in Europe: The across-country variation did not shrink in the past decade. Acta Oncol 2012;51(4):441-53.

Rantner LJ, Stuhlinger MC, Nowak CN, Spuller K, Etsadashvili K, Stuhlinger X, Berger T, Dichtl W, Gothe RM, Fischer G, Hintringer F. Localizing the accessory pathway in ventricular preexcitation patients using a score based algorithm. Methods Inf Med 2012;51(1):3-12.

Nuijten MJ, Aultman R, Carpeno Jde C, Vergnenegre A, Chouaid C, Walzer S, Siebert U. An indirect comparison of the efficacy of bevacizumab plus carboplatin and paclitaxel versus pemetrexed with cisplatin in patients with advanced or recurrent non-squamous adenocarcinoma non-small cell lung cancer. Curr Med Res Opin 2011;27(11):2193-201.

Zechmeister I, Ara R, Ward S, Stollenwerk B. Have statins met our expectations? A comparison of excepted health gains from statins with epidemiological trends in Austria. Journal of Public Health 2011;20(1):31-9.

Geiger-Gritsch S, Muehlboeck H, Harrasser L, Oberaigner W. Cancer in the Elderly and Gender Aspects - Situation in Tyrol. Magazine of European Medical Oncology 2011;4(4):232-35.

Siebert U, Jahn B, Muhlberger N, Fricke F-U, Schoeffski O. [Decision Analysis and Modelling] [German]. In: Schöffski O, Graf von der Schulenburg JM, eds. Economic Evaluations, 4th. ed. Berlin, Heidelberg, New York: Springer, 2011;275-324.

Baeuml J, Bose-O’Reilly S, Gothe RM, Lettmeier B, Roider G, Drasch G, Siebert U. Human biomonitoring data from mercury exposed miners in six artisanal small-scale gold mining areas in Asia and Africa. Minerals 2011;1(1):122-43.

Sels J, Tonino P, Siebert U, Fearon W, Van't Veer M, De Bruyne B, Pijls N. Fractional Flow Reserve in Unstable Angina and Non-ST-Segment Elevation Myocardial Infarction: Experience From the FAME (Fractional flow reserve versus Angiography for Multivessel Evaluation) Study. J Am Coll Cardiol Intv 2011;4(11):1183-9.

Afandiyev I, Alimonti A, Barbosa Jr F, Besbelli N, Bose-O'Reilly S, Conti M, Danbayev Z, Dargan P, Domingo J, Drasch G, Dumitru C, Flegal A-R, Gardner R, Gecim N, Goldman L, Graczyk H, Gvineria I, Horvat M, De Kom J, Lettmeier B, Makalinao I, McCarty K, Adler-Miserendino R, Najaran L, Nyland J, Pantea V, Sakamoto M, Sharshenova A, Silbergeld E, Stern A, Steckling N, Wells E, Yamamoto M. Children’s Exposure to Mercury Compounds. Geneva, Switzerland: WHO Document Production Services, 2010.

Amitai Y, Bakir H, Besbelli N, Boese-O'Reilly S, Cebrian M, Dai Y, Dargan P, Easson E, Graber N, Khassouani C, Healy N, Kolacinsiki Z, Laborde A, Landrigan P, Lanphear B, Mathee A, Mathieu M, McWeeny W. Childhood lead Poisoning. Geneva, Switzerland: WHO Document Production Services, 2010.

Schnell-Inderst P, Hunger T, Hintringer K, Schwarzer R, Seifert-Klauss V, Gothe H, Wasem J, Siebert U. [Individual health services. Series of the German Institute for Medical Documentation and Information commissioned by the Federal Ministry of Health] [German]. Health Technology Assessment. Vol. 113 (1. Auflage). Köln: DAHTA@DIMDI, 2011.

Gothe H, Storz P, Daroszewska A, Häussler B. Innovationen in der Anti-Aging-Medizin - Eine Analyse des Angebots, der Versorgungssituation und zukünftiger Entwicklungen an drei ausgewählten Beispielen. In: Maio G, ed. Altwerden ohne alt zu sein? - Ethische Grenzen der Anti-Aging-Medizin. Freiburg: Verlag Karl Alber, 2011;71-93.

Ammenwerth E, Schnell-Inderst P, Hörbst A. Patient Empowerment by Electronic Health Records: First Results of a Systematic Review on the Benefit of Patient Portals. e-health Across Borders without Boundaries. EFMI Special Topic Conference (STC), April 14-15. Laško, Slovenia, Studies in Health Technology and Informatics. Amsterdam: IOS Press 2011; 165:63-67.

Dams J, Bornschein B, Reese JP, Conrads-Frank A, Oertel W, Siebert U, Dodel R. Modelling the cost effectiveness of treatments for Parkinson´s Disease - A methodological review. Pharmacoeconomics 2011;29(12):1025-49.

Mangen M-J, Gibbons C, Kretzschmar M, de Wit A, Havelaar A, van Lier A, Bijerk P, Siebert U, Jahn B, Muhlberger N, Krämer A, Plaß D, Pinheiro P, Ricciardi W, Franco E, Longhi S, Murianni L, de Waure C, Lai T, Rüütel K. Current and future Burden of Communicable Diseases in the European Union and EEA/ EFTA countries (BCoDE) - Methodology protocol [Technical Report]. Stockholm, Sweden: European Centre for Disease Prevention Control (ECDC), 2011;1-43.

Oberaigner W, Siebert U. Do women with cancer have better survival as compared to men after adjusting for staging distribution? Eur J Public Health 2011;21(3)291:387-391.

Oberaigner W, Daniaux M, Geiger-Gritsch S, Knapp R, Siebert U, Buchberger W. Introduction of organised mammography screening in Tyrol: results following first year of complete rollout. BMC PH 2011;11(673).

Baeuml J, Bose-O’Reilly S, Lettmeier B, Maydl A, Messerer K, Roider G, Drasch G, Siebert U. Applicability of two mobile analysers for mercury in urine in small-scale gold mining areas. International Journal Hygiene Environmental Health 2011;215(1):64-7.

Goehler A, Geisler BP, Manne JM, Jahn B, Conrads-Frank A, Schnell-Inderst P, Gazelle GS, Siebert U. Decision-Analytic models to simulate health outcomes and costs in heart failure: a systematic review. Pharmacoeconomics 2011;29(9):753-69.

Jahn R, Diehm C, Driller E, Hessel F, Ommen O, Pfaff H, Siebert U, Pittrow D, Wasem J, Neumann A. Effect of guideline-orientation on the outcomes of peripheral arterial disease in primary care. Current Medical Research and Opinion 2011;27(6)286:1183-1190.

Sroczynski G, Schnell-Inderst P, Muhlberger N, Lang K, Aidelsburger P, Wasem J, Mittendorf T, Engel J, Hillemanns P, Petry KU, Kramer A, Siebert U. Cost-effectiveness of primary HPV screening for cervical cancer in Germany - a decision analysis. Eur J Cancer 2011;47(11):1633-46.

Mickisch GH, Schwander B, Escudier B, Bellmunt J, Maroto J P, Porta C, Walzer S, Siebert, U. Indirect treatment comparison of bevacizumab + interferon-α-2a vs tyrosine kinase inhibitors in first-line metastatic renal cell carcinoma therapy. ClinicoEconomics and Outcomes Research 2011;3:19-27.

von Campenhausen S, Winter Y, Silva AR, Sampaio C, Ruzicka E, Barone P, Poewe W, Guekht A, Mateus C, Pfeiffer KP, Berger K, Skoupa J, Botzel K, Geiger-Gritsch S, Siebert U, Balzer-Geldsetzer M, Oertel WH, Dodel R, Reese JP. Costs of illness and care in Parkinson's Disease: An evaluation in six countries. Eur Neuropsychopharmacol 2011;21(2):180-91.

Oberaigner W, Buchberger W, Frede T, Daniaux M, Knapp R, Marth C, Siebert U. Introduction of organised mammography screening in Tyrol: results of a one-year pilot phase. BMC Public Health 2011;11(91):1-28.

Steckling N, Boese-O'Reilly S, Gradel C, Gutschmidt K, Shinee E, Altangerel E, Badrakh B, Bonduush I, Surenjav U, Ferstl P, Roider G, Sakamoto M, Sepai O, Drasch G, Lettmeier B, Morton J, Jones K, Siebert U, Hornberg C. Mercury exposure in female artisanal small-scale gold miners (ASGM) in Mongolia: An analysis of human biomonitoring (HBM) data from 2008. Sci Total Environ 2011;409(5):994-1000.

Leitner H, Bose-O'Reilly S, Oberaigner W, Mark M, Brezinka C, Siebert U. Perinatale Mortalität nach Herkunftsland der Mutter in Tirol 200-2008 [Perinatal Mortality by Mother's Country of Origin in Tyrol 2000-2008]. Gesundheitswesen 2011;73(8-9):469-76.

Fearon WF, Bornschein B, Tonino PA, Gothe RM, Bruyne BD, Pijls NH, Siebert U. Economic evaluation of fractional flow reserve-guided percutaneous coronary intervention in patients with multivessel disease. Circulation 2010;122(24):2545-50.

Caro JJ, Nord E, Siebert U, McGuire A, McGregor M, Henry D, de Pouvourville G, Atella V, Kolominsky-Rabas P. The efficiency frontier approach to economic evaluation of health-care interventions. Health Econ 2010;19(10):1117-27.

Caro JJ, Nord E, Siebert U, McGuire A, McGregor M, Henry D, de Pouvourville G, Atella V, Kolominsky-Rabas P. IQWiG methods - a response to two critiques. Health Econ 2010;19(10):1137-8.

Geiger-Gritsch S, Stollenwerk B, Miksad R, Guba B, Wild C, Siebert U. Safety of bevacizumab in patients with advanced cancer: a meta-analysis of randomized controlled trials. Oncologist 2010:15(11):1179-91.

Siebert U, Schnell-Inderst P, Hintringer K. Health Technology Assessment. medicine & health 2011. GoingInternational Polak, G., 2010;229-31.

Oberbichler S, Memelink M, Wozak F, Jahn B, Schabetsberger T, Hoerbst A, Siebert U. INSYDE - Integration of Health System Data and Exchange - A Status Report. OCG Books 2010;264:181-87.

Neumann PJ, Drummond MF, Jonsson B, Luce BR, Schwartz JS, Siebert U, Sullivan SD. Evaluating HTA principles - Letters to the Editor. Int J Technol Assess Health Care 2010;26(4):429-30.

Lettmeier B, Drasch K, Boese-O'Reilly S, Drasch G. Vorschlag für Human-Biomonitoring-(HBM)-Werte für Quecksilberdampf – Teil I: Erwachsene. Umweltmedizin in Forschung und Praxis 2010;15(4):221-228.

Lettmeier B, Böse-O’Reilly S, Roider G, Drasch G. Proposal for a Revised Reference Concentration (RfC) for mercury vapour in adults. Science of the total Environment 2010;408:3530-35.

Leichtfried V, Kantner-Rumplmair W, Bartenbach C, Guggenbichler H, Gothe R, Schobersberger W. Bright light therapy: Minimizing light induced side effects with an innovative light setup. International Journal of Psychiatry in Clinical Practice 2010;14(4):309-12.

Bose-O'Reilly S, McCarty K, Steckling N, Lettmeier B. Mercury exposure and children’s health. Current Problems in Pediatric and Adolescent Health Care 2010;40(8):186-215.

Nuijten M, Heigener D, Bischoff H, Chouaid C, Vergnenègre A, Carpeño J, Aultman R, Walzer S, Siebert U. Effectiveness of bevacizumab- and pemetrexed-cisplatin treatment for patients with advanced non-squamous non-small cell lung cancer. Lung Cancer 2010;69(Supplement 1):4-10.

Klein S, Thiede M, Scholz C, Höer A, Albrecht M, Häussler B u.M.v. Stier V, Bleß H, de Millas C (IGES) / Schmidt H, Jahn R, Staudt S, Farrenkopf N, Lux G, Weegen L, Thomas D, Wasem J (Universität Duisburg-Essen) / Sussex J, Shah K, Butler J (Australian Centre for Economic Research on Health, The Australian National University, Canberra, Australia) (OHE Consulting) / Mühlberger N, Gothe H, Schwarzer R, Schnell-Inderst P, Sroczynski G, Siebert U u.M.v. Mayer C, Schall I, Iglesias C (UMIT). Gutachten zur Verbesserung der Wirtschaftlichkeit von Impfstoffen in Deutschland. Abschlussbericht. Im Auftrag des Bundesministeriums für Gesundheit [Hrsg.], Berlin 2010.

Luce BR, Drummond M, Jonsson B, Neumann PJ, Schwartz JS, Siebert U, Sullivan SD. EBM, HTA, and CER: clearing the confusion. Milbank Q 2010;88(2):256-76.

von Lengerke T, Hagenmeyer EG, Gothe H, Schiffhorst G, Happich M, Häussler B. Excess health care costs of obesity in adults with diabetes mellitus: a claims data analysis. Exp Clin Endocrinol Diabetes 2010; 118(8):496-504.

Hagenmeyer EG, Gothe H, Landgraf W, Kulik M, Schiffhorst G, Häussler B. Ressourcen-Inanspruchnahme und Kosten der Behandlung von Typ-2-Diabetikern unter Insulin-glargin- oder Insulindetemir-Therapie (LIVE-KK): Analyse von Krankenkassen-Routinedaten mittels Propensity Score Matching. Gesundheitsökonomie und Qualitätsmanagement 2010; 15:121–6.

Schiffhorst G, Freytag A, Höer A, Happich M, Häussler B, Gothe H. Pain-specific diagnosis patterns in claims data - Identification by means of classification and regression trees (CART). Gesundheitswesen 2010; 72(6):347-55.

Ostendorf L, Gothe H. Antikörpertherapie in der Onkologie. Innovationen im Spiegel eines Prognoseinstrumentes. In: Häussler B, Isenberg T, Klusen N, Penk A. (Hrsg.): Jahrbuch der medizinischen Innovationen, Band 6: Innovation und Gerechtigkeit. ISBN 978-3-7945-2683-3. S. 129-136. Schattauer, Stuttgart, Germany, 2010.

Gothe H, Klein S, Storz P, Höer A, Haag C, Marx P, Häussler B. Erkenntnisse zur Arzneimitteltherapie im Zeitverlauf: Frühe Ergebnisse und späte Umsetzung? Retrospektiove Untersuchung für ausgewählte Arzneimittel-Wirkstoffgruppen. Schriftenreihe Forschung und Entwickung im Gesundheitswesen, Band 2, ISBN 978-3-8329-5252-5. Nomos Verlagsgesellschaft, Baden-Baden, Germany, 2010.

Expertenrat des Bundesministeriums für Bildung und Forschung (Gothe H, Grundwald A, Hackler E, Meyer S, Mollenkopf H, Niederlag W, Rienhoff O, Steinhagen-Thiessen, Szymkowiak C): Loccumer Memorandum. Technische Assistenzsysteme für den demographischen Wandel – eine generationenübergreifende Innovationsstrategie. Empfehlungen des Expertenrates des BMBF. Bundesministerium für Bildung und Forschung, Berlin, Germany, 2010.

Schmidt T, Mühlberger N, Chemelli-Steingruber IE, Strasak A, Kofler B, Chemelli A, Siebert U. Benefit, risks and cost-effectiveness of screening for abdominal aortic aneurysm. Rofo: Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin 2010;182(7):573-80.

Pijls NH, Fearon WF, Tonino PA, Siebert U, Ikeno F, Bornschein B, van't Veer M, Klauss V, Manoharan G, Engstrom T, Oldroyd KG, Ver Lee PN, MacCarthy PA, De Bruyne B. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention in patients with multivessel coronary artery disease: 2-year follow-up of the FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) study. J Am Coll Cardiol 2010;56(3):177-84.

Verhoef TI, Redekop WK, Darba J, Geitona M, Hughes DA, Siebert U, de Boer A, Maitland-van der Zee AH, Barallon R, Briz M, Daly A, Haschke-Becher E, Kamali F, Kirchheiner J, Manolopoulos VG, Pirmohamed M, Rosendaal FR, van Schie RM, Wadelius M. A systematic review of cost-effectiveness analyses of pharmacogenetic-guided dosing in treatment with coumarin derivatives. Pharmacogenomics 2010;11(7):989-1002.

Strasser B, Siebert U, Schobersberger W. Resistance training in the treatment of the metabolic syndrome: a systematic review and meta-analysis of the effect of resistance training on metabolic clustering in patients with abnormal glucose metabolism. Sports Med 2010;40(5):397-415.

Sroczynski G, Schnell-Inderst P, Mühlberger N, Lang K, Aidelsburger P, Wasem J, Mittendorf T, Engel J, Hillemanns P, Petry KU, Krämer A, Siebert U. [Decision-analytic modeling to evaluate the long-term effectiveness and cost-effectiveness of HPV-DNA testing in primary cervical cancer screening in Germany]. Health Technology Assessment. Cologne: DIMDI, 2010;1-127.

Basner M, Siebert U. Markov processes for the prediction of aircraft noise effects on sleep. Medical Decision Making 2010; 30(2):275-89.

Jahn B, Theurl E, Siebert U, Pfeiffer KP. Tutorial in medical decision modeling incorporating waiting lines and queues using discrete event simulation. Value Health 2010;13(4):501-6.

Grander W, Dunser M, Stollenwerk B, Siebert U, Dengg C, Koller B, Eller P, Tilg H. C-reactive protein levels and post-ICU mortality in nonsurgical intensive care patients. Chest 2010;138(4):856-62.

Sroczynski G, Schnell-Inderst P, Mühlberger N, Lang K, Aidelsburger P, Wasem J, Mittendorf T, Engel J, Hillemanns P, Petry KU, Krämer A, Siebert U. [Decision-analytic modeling to evaluate the long-term effectiveness and cost-effectiveness of HPV-DNA testing in primary cervical cancer screening in Germany]. GMS Health Technol Assess 2010;6(Doc05 ):1-13.

Rotter T, Kinsman L, James E, Machotta A, Gothe H, Willis J, Snow P, Kugler J. Clinical pathways: effects on professional practice, patient outcomes, length of stay and hospital costs. Cochrane Database of Systematic Reviews. Chichester, UK: John Wiley & Sons, Ltd, 2010.

Ammenwerth E, Schnell-Inderst P, Siebert U. Vision and challenges of Evidence-Based Health Informatics: a case study of a CPOE meta-analysis. Int J Med Inform 2010;79(4):e83-8.

Stollenwerk B, Stock S, Siebert U, Lauterbach KW, Holle R. Uncertainty assessment of input parameters for economic evaluation: Gauss's error propagation, an alternative to established methods. Med Decis Making 2010;30(3):304-13.

Oberaigner W, Buchberger W, Frede T, Knapp R, Marth C, Siebert U. Breast cancer incidence and mortality in Tyrol/Austria after fifteen years of opportunistic mammography screening. BMC Public Health 2010;10(1):86.

Konig A, Bleie O, Rieber J, Jung P, Schiele TM, Sohn HY, Leibig M, Siebert U, Klauss V. Intravascular ultrasound radiofrequency analysis of the lesion segment profile in ACS patients. Clin Res Cardiol 2010;99(2):83-91.

Sroczynski G, Esteban E, Conrads-Frank A, Schwarzer R, Mühlberger N, Wright D, Zeuzem Z, Siebert U. Long-term effectiveness and cost-effectiveness of antiviral treatment in hepatitis C. J Viral Hep 2010;17(1):34-50.

Bose-O'Reilly S, Drasch G, Beinhoff C, Rodrigues-Filho S, Roider G, Lettmeier B, Maydl A, Maydl S, Siebert U. Health assessment of artisanal gold miners in Indonesia. Sci Total Environ 2010;408(4):713-25.

Bose-O'Reilly S, Drasch G, Beinhoff C, Tesha A, Drasch K, Roider G, Taylor H, Appleton D, Siebert U. Health assessment of artisanal gold miners in Tanzania. Sci Total Environ 2010;408(4):796-805.

International Working Group for HTA Advancement, Neumann PJ, Drummond MF, Jönsson B, Luce BR, Schwartz JS, Siebert U, Sullivan SD. Are Key Principles for improved health technology assessment supported and used by health technology assessment organizations? International Journal of Technology Assessment in Health Care 2010; 26(1):71-78.

Schnell-Inderst P, Schwarzer R, Gohler A, Grandi N, Grabein K, Stollenwerk B, Manne J, Klauss V, Siebert U, Wasem J. Prognostic value, clinical effectiveness, and cost-effectiveness of high-sensitivity C-reactive protein as a marker for major cardiac events in asymptomatic individuals: a health technology assessment report. Int J Technol Assess Health Care 2010;26(1):30-9.

Geisler BP, Widerberg KF, Berghofer A, Willich SN. Leadership in Health Care: Developing a Post-merger Strategy for Europe’s Largest University Hospital J Health Organ Manag 2010 4(3):258-76.

Kollensperger M, Geser F, Ndayisaba JP, Boesch S, Seppi K, Ostergaard K, Dupont E, Cardozo A, Tolosa E, Abele M, Klockgether T, Yekhlef F, Tison F, Daniels C, Deuschl G, Coelho M, Sampaio C, Bozi M, Quinn N, Schrag A, Mathias CJ, Fowler C, Nilsson CF, Widner H, Schimke N, Oertel W, Del Sorbo F, Albanese A, Pellecchia MT, Barone P, Djaldetti R, Colosimo C, Meco G, Gonzalez-Mandly A, Berciano J, Gurevich T, Giladi N, Galitzky M, Rascol O, Kamm C, Gasser T, Siebert U, Poewe W, Wenning GK. Presentation, diagnosis, and management of multiple system atrophy in Europe: final analysis of the European multiple system atrophy registry. Mov Disord 2010;25(15):2604-12.

Tonino PA, De Bruyne B, Pijls NHJ, Siebert U, Ikeno F, van't Veer M, Klauss V, Manoharan G, Engstrøm T, Oldroyd KG, Ver Lee PN, MacCarthy PA, Fearon WF, for the FAME Study Investigators. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. New England Journal of Medicine 2009;360(3):213-24.

Rotter T, Kinsman L, James E, Machotta A, Gothe H, Kugler J. The experience of conducting a Cochrane systematic review of the impact of clinical pathways on professional practice, patient outcomes, length of stay and hospital costs. International Journal of Care Pathways 2009; 13:62–6.

Gothe H. Arbeits- und Berufszufriedenheit von Ärzten – eine Übersicht der internationalen Literatur. In: Schwartz FW, Angerer P (Hrsg.): Arbeitsbedingungen und Befinden von Ärztinnen und Ärzten – Befunde und Interventionen. Report Versorgungsforschung Band 2. ISBN 978-3-7691-3438-4. S. 7-14. Bundesärztekammer, Berlin, 2009.

Gothe H, Storz P, Daroszewska A, Freytag A, Häussler B. Telemonitoring herzinsuffizienter Patienten: Gesundheitliche und ökonomische Effekte der künftigen Nutzung von AAL-Technologien. In: Schreyer G, Hayn D, Ammenwerth E (Hrsg.): eHealth 2009 – Health Informatics meets eHealth. ISBN 978-3-85403-250-2. S. 11-16. Österreichische Computer Gesellschaft, Wien, Austria, 2009.

Freytag A, Schiffhorst G, Thoma R, Strick K, Gries C, Becker A, Treede RD, Müller-Schwefe G, Casser HR, Luley C, Höer A, Ujeyl M, Gothe H, Kugler J, Glaeske G, Häussler B. Identifikation und Gruppierung von Schmerzpatienten anhand von Routinedaten einer Krankenkasse. Schmerz 2009; 24:12-22.

Trikalinos TA, Siebert U, Lau J. Decision-analytic modelling to evaluate benefits and harms of medical tests. Medical Tests-White Paper Series. Rockville: Agency for Healthcare Research and Quality (AHRQ), 2009;1-15. 

Wild C, Simpson S, Douw K, Geiger-Gritsch S, Mathis S, Langer T. Information service on new and emerging health technologies: Identification and prioritization processes for a European Union-wide newsletter. International Journal of Technology Assessment in Health Care 2009;25(SupplementS2):48-55.

von Campenhausen S, Winter Y, Gasser J, Seppi K, Reese JP, Pfeiffer KP, Geiger-Gritsch S, Botzel K, Siebert U, Oertel WH, Dodel R, Poewe W. [Cost of illness and health service patterns in Morbus Parkinson in Austria]. Wien Klin Wochenschr 2009;121(17-18):574-82.

Geiger-Gritsch S, Piso B, Guba B, Felder-Puig R. Stentgraftimplantation bei Erkrankungen der Aorta ascendens. Der Chirurg 2009;80(7):634-640.

Geisler BP. Health state survey-derived utilities in cost-utility analysis--a call to action. Value Health 2010;13(2):159.

Schwarzer R, Schnell-Inderst P, Grabein K, Gohler A, Stollenwerk B, Grandi N, Klauss V, Wasem J, Siebert U. [Prognostic value and clinical effectiveness of high sensitivity C-reactive protein as a marker in primary prevention of major cardiac events]. Z Evid Fortbild Qual Gesundhwes 2009;103(6):319-29.

Jahn B, Pfeiffer KP, Theurl E, Tarride JE, Goeree R. Capacity constraints and cost-effectiveness: a discrete event simulation for drug-eluting stents. Med Decis Making 2010;30(1):16-28.

Johnson ML, Crown W, Martin BC, Dormuth CR, Siebert U. Good research practices for comparative effectiveness research: analytic methods to improve causal inference from nonrandomized studies of treatment effects using secondary data sources: The ISPOR Good Research Practices for Retrospective Database Analysis Task Force Report - Part III. Value in Health 2009; 12(8):1062-1073.

Oberaigner W, Siebert U. Are survival rates for Tyrol published in the Eurocare studies biased? Acta Oncol 2009;48(7):984 - 991.

Konig A, Bleie O, Rieber J, Jung P, Schiele TM, Sohn HY, Leibig M, Siebert U, Klauss V. Intravascular ultrasound radiofrequency analysis of the lesion segment profile in ACS patients. Clin Res Cardiol 2010;99(2):83-91.

Cox E, Martin BC, Van Staa T, Garbe E, Siebert U, Johnson ML. Good research practices for comparative effectiveness research: Approaches to mitigate bias and confounding in the design of nonrandomized studies of treatment effects using secondary data sources: The International Society for Pharmacoeconomics and Outcomes Research Good Research Practices for Retrospective Database Analysis Task Force Report-Part II. Value Health 2009;12(8):1053-1061.

Trikalinos TA, Siebert U, Lau J. Decision-analytic modeling to evaluate benefits and harms of medical tests: Uses and limitations. Med Decis Making 2009;29(5):E22-9.

Mehrhof F, Loffler M, Gelbrich G, Ozcelik C, Posch M, Hense HW, Keil U, Scheffold T, Schunkert H, Angermann C, Ertl G, Jahns R, Pieske B, Wachter R, Edelmann F, Wollert KC, Maisch B, Pankuweit S, Erbel R, Neumann T, Herzog W, Katus H, Muller-Tasch T, Zugck C, Dungen HD, Regitz-Zagrosek V, Lehmkuhl E, Stork S, Siebert U, Wasem J, Neumann A, Gohler A, Anker SD, Kohler F, Mockel M, Osterziel KJ, Dietz R, Rauchhaus M. A network against failing hearts--introducing the German "Competence Network Heart Failure". Int J Cardiol 2010;145(1):135-8.

Konig A, Bleie O, Dudek D, Marso S, Rogers JH, Dave R, Tanaka K, Siebert U, Wijns W, Klauss V. Coronary plaque dimensions and composition by intravascular ultrasound radio frequency lesion segment analysis in stable and unstable angina patients. Coron Artery Dis 2009;20(5):309-16.

Schwarzer R, Siebert U. Methods, procedures, and contextual characteristics of health technology assessment and health policy decision making: Comparison of health technology assessment agencies in Germany, United Kingdom, France, and Sweden. Int J Technol Assess Health Care 2009;25(3):305-14.

Zechmeister I, Blasio BF, Garnett G, Neilson AR, Siebert U. Cost-effectiveness analysis of human papillomavirus-vaccination programs to prevent cervical cancer in Austria. Vaccine 2009;27(37):5133-41.

Hellmann-Schoierer J, Bose-O'Reilly S. [Preventive assistants in paediatric outpatient clinics.] Gesundheitswesen 2009;71(06):329-31.

Geisler BP, Levin-Scherz JK. Additional factors that could improve cost-effectiveness of pharmacogenetic-guided dosing in warfarin therapy. Ann Intern Med 2009;151(1):71; author reply 71.

Geisler BP, van Dam R, Gazelle GS, Goehler A. Risk of bias in meta-analysis on erythropoietin-stimulating agents in heart failure. Heart 2009;95(15):1278-9; author reply 1279.

Siebert U, Sroczynski G, Aidelsburger P, Rossol S, Wasem J, Manns MP, McHutchison JG, Wong JB, German Hepatitis C Model (GEHMO) Group, International Hepatitis Interventional Therapy (IHIT) Group. Clinical effectiveness and cost-effectiveness of tailoring chronic hepatitis C treatment with peginterferon alpha-2b plus ribavirin to HCV genotype and early viral response: A decision analysis on new German guidelines. Pharmacoeconomics 2009;27(4):341-54.

Schnell-Inderst P, Schwarzer R, Göhler A, Grandi N, Grabein K, Stollenwerk B, Klauss V, Wasem J, Siebert U. Stellenwert des hochsensitiven C-reaktiven Proteins (hs-CRP) als Marker für Herzinfarktgefährdung. Ein Health Technology Assessment im Auftrag des Deutschen Institutes für Medizinische Dokumentation und Information (DIMDI), Berichtsnummer 216, Schriftenreihe Health Technology Assessment Bd. 81, Köln: DIMDI, 2009, pp.1-318.

Schnell-Inderst P, Schwarzer R, Göhler A, Grandi N, Grabein K, Stollenwerk B, Klauß V, Wasem J, U. S. Endbericht zum Stellenwert des hochsensitiven C-reaktiven Proteins (hs-CRP) als Marker für Herzinfarktgefährdung. GMS Health Technol Assess 2009;5(Doc06).

Neumann A, Jahn R, Diehm C, Driller E, Hessel F, Lux G, Ommen O, Pfaff H, Siebert U, Wasem J, and on behalf of the Patient Care Evaluation-Peripheral Arterial Disease (PACE-PAD) Study Investigators. Presentation and medical management of peripheral arterial disease in general practice: rationale, aims, design and baseline results of the PACE-PAD Study. J Public Health 2009;17(2):127-35.

Maringer B, Zietemann V, Ratzinger G, Siebert U. [Effectiveness of omega-3-fatty-acids in psoriasis. A systematic review]. Aktuel Ernahrungsmed 2009;34(4):195-200.

Göhler A, Geisler BP, Manne JM, Kosiborod M, Zhang Z, Weintraub WS, Spertus JA, Gazelle GS, Siebert U, Cohen DJ. Utility Estimates for Decision - Analytic Modeling in chronic heart failure - health states based on New York Heart Association classes and number of rehospitalizations. Value in Health 2009;12(1):185-7.

Geisler BP, Siebert U, Gazelle GS, Cohen DJ, Göhler A. Deterministic sensitivity analysis for First-Order Monte Carlo Simulations: A technical note. Value in Health 2009;12(1):96-7.

Mühlberger N, Schwarzer R, Lettmeier B, Sroczynski G, Zeuzem S, Siebert U. HCV-related burden of disease in Europe: a systematic assessment of incidence, prevalence, morbidity, and mortality. BMC Public Health 2009;9(1):34.

Sroczynski G, Esteban E, Conrads-Frank A, Schwarzer R, Muhlberger N, Wright D, Zeuzem S, Siebert U. Long-term effectiveness and cost-effectiveness of screening for hepatitis C virus infection. Eur J Public Health 2009;19(3):245-53.

Stollenwerk B, Gerber A, Lauterbach KW, Siebert U. The German Coronary Artery Disease Risk Screening Model: Development, validation and application of a decision-analytic model for coronary artery disease prevention with statins. Med Decis Making 2009;29:619-33.

Siebert U, Conrads-Frank A, Schwarzer R, Lettmeier B, Sroczynski G, Zeuzem S, Mühlberger N. DALYs in chronic hepatitis C - a pan-European perspective In: Preedy VR, Watson RR, eds. Handbook of Disease Burdens and Quality of Life Measures. New York: Springer, 2009;1323-1334.

Gohler A, Conrads-Frank A, Worrell SS, Geisler BP, Halpern EF, Dietz R, Anker SD, Gazelle GS, Siebert U. Decision-analytic evaluation of the clinical effectiveness and cost-effectiveness of management programmes in chronic heart failure. Eur J Heart Fail 2008;10(10):1026-32.

Alimonti A, Bose-O'Reilly S, Moshammer H, van den Hazel PJ. Preface: Children's health and environment. Int J Environment and Health 2008;2(3/4):273-5.

Boese-O'Reilly S, Drasch G, Lettmeier B, Roider G, Siebert U. Reply to the letter to the editor by J.G. Dorea "Health hazard for infants: Breast-milk mercury or non-breastfeeding? A dilemma for mothers exposed to mercury vapours". Int J Hyg Environ Health 2008;212(2):235-7.

Institute for Quality and Efficiency in Health Care (IQWiG). Methods for assessment of the relation of benefits to costs in the German Statutory Health Care System. V. 1.0. (Members of the IQWiG International Expert Panel: Attella V, Caro J, Pouvourville G, Henry D, McGregor M, McGuire A, Nord E, Siebert U). Cologne: IQWiG, 2008;68.

Lob-Corzilius T, Wermuth I, Hellmann J, Petersen E, Böse-O’Reilly S. Präventionsassistentin in der Kinder- und Jugendmedizin. Eine umweltmedizinische Weiterqualifikation für medizinische Assistenzberufe. Umweltmed Forsch Prax 2008;13(6):373-8.

Stock S, Stollenwerk B, Klever-Deichert G, Redaelli M, Buscher G, Graf C, Mohlendick K, Mai J, Gerber A, Lungen M, Lauterbach KW. Preliminary analysis of short-term financial implications of a prevention bonus program: first results from the German Statutory Health Insurance. Int J Public Health 2008;53(2):78-86.

Siebert U, Bornschein B, Schnell-Inderst P, Rieber J, Pijls N, Wasem J, Klauss V. [Measurement of fractional flow reserve to guide the decision on percutaneous coronary interventions. [German]. Health Technology Assessment Vol. 69 (Series of the German Institute for Medical Documentation and Information commissioned by the Federal Ministry of Health). Health Technology Assessment  Vol. 69. Cologne: DIMDI, 2008.

Ramoner R, Rahm A, Gander H, Stollenwerk B, Falkensammer C, Leonhartsberger N, Thurnher M. Serum antibodies against Saccharomyces cerevisiae: a new prognostic indicator in metastatic renal-cell carcinoma. Cancer Immunol Immunother 2008;57(8):1207-14.

Miksad RA, Zietemann V, Gothe R, Schwarzer R, Conrads-Frank A, Schnell-Inderst P, Stollenwerk B, Siebert U. Progression-free survival as a surrogate endpoint in advanced breast cancer. Int J Technol Assess Health Care 2008;24(4):371-83.

Graf von der Schulenburg JM, Greiner W, Jost F, Klusen N, Kubin M, Leidl R, Mittendorf T, Rebscher H, Schoeffski O, Vauth C, Volmer T, Wahler S, Wasem J, Weber C. German recommendations on health economic evaluation: Third and updated version of the Hanover Consensus. Value Health 2008;11(4):539-44.

Gohler A, Geisler BP, Manne JM, Kosiborod M, Zhang Z, Weintraub WS, Spertus JA, Gazelle GS, Siebert U, Cohen DJ. Utility estimates for decision-analytic modeling in chronic heart failure-health states based on New York Heart Association Classes and number of rehospitalizations. Value Health 2008;12(1):185-7.

Boese-O'Reilly S. Das geplante Praeventionsgesetz aus paediatrischer Sicht. Verhältnisse und Verhalten aendern. Weiterbildung 2008;3:8-11.

Boese-O'Reilly S, Hellmann J. . Primaere Praevention und Gesundheitsfoerderung - das geplante Praeventionsgesetz aus paediatrischer Sicht. Weiterbildung 2008;3.

Boese-O'Reilly S, Lettmeier B, Cao TL, Siebert U, Tesha AL, Pronczuk J, et al. Health and environmental training in mercury-contaminated areas. Int J Environment and Health 2008;1(4):621-37.

Boese-O'Reilly S, Lettmeier B, Gothe RM, Beinhoff C, Siebert U, Drasch G. Mercury as a serious health hazard for children in gold mining areas. Environ Res 2008;107(1):89-97.

Hellmann J, Boese-O'Reilly S. Prävention und Gesundheitsförderung - mehr als nur Verhütung von Krankheit. Weiterbildung 2008(3):40-43.

Hellmann J, Lob-Corzilius T, Boese-O'Reilly S, Petersen E. Vorbildprojekt zur Vorbeugung - Fünf Jahre Curriculum Prävention im Kindes- und Jugendalter. Weiterbildung 2008(3):16-19.

Drummond M, Schwartz JS, Jönsson B, Luce B, Neumann P, Siebert U, Sullivan S. Response from the authors of "Key principles for the improved conduct of health technology assessments for resource allocation decisions". Int J Technol Assess Health Care 2008;24(3):367-8.

Drummond MF, Schwartz JS, Jönsson B, Luce BR, Neumann PJ, Siebert U, Sullivan SD. Key principles for the improved conduct of health technology assessments for resource allocation decisions.Int J Technol Assess Health Care 2008;24(3):244-58.

Ammenwerth E, Schnell-Inderst P, Machan C, Siebert U. The effect of electronic prescribing on medication errors and adverse drug events: A systematic review. J Am Med Inform Assoc 2008;15(5):585-600.

Mühlberger N, Sroczynski G, Esteban E, Mittendorf T, Miksad RA, Siebert U. Cost-effectiveness of primarily human papillomavirus-based cervical cancer screening in settings with currently established Pap screening: A systematic review commissioned by the German Federal Ministry of Health. International Journal of Technology Assessment in Health Care 2008;24(2):184-92.

Lettmeier B; Mühlberger N, Schwarzer E, Sroczynski G, Wright D, Zeuzem S, Siebert U. Market uptake of new antiviral drugs for the treatment of hepatitis C. Journal of Hepatology 2008;49(4):528-36.

Boese-O'Reilly S, Wermuth I, Hellmann J, Siebert U, Lob-Corzilius T. [Promotion of breast feeding in paediatric outpatient settings]. [German] Gesundheitswesen 2008;70(Suppl 1):S34-36.

König A, Kilian E, Sohn HY, Rieber J, Schiele TM, Siebert U, Gothe RM, Reichart B, Klauss V. Assessment and characterization of time-related differences in plaque composition by intravascular ultrasound-derived radiofrequency analysis in heart transplant recipients. Journal of Heart & Lung Transplantation 2008;27(3):302-9.

Stempfle HU, Alt A, Stief J, Siebert U. The Munich score: a clinical index to predict survival in ambulatory patients with chronic heart failure in the era of new medical therapies. Journal of Heart & Lung Transplantation 2008;27(2):222-8.

Siebert U, Bornschein B, Schnell-Inderst P, Rieber J, Pijls N, Wasem J, Klauss V. [Measurement of fractional flow reserve to guide decisions for percutaneous coronary intervention] (German; Original Title: Messung der fraktionierten Flussreserve zur Indikationsstellung der perkutanen Koronarintervention). GMS Health Technol Assess 2008;4(Doc07):1-12.

Siebert U. [Using decision-analytic modelling to transfer international evidence from health technology assessment to the context of the German health care system. A HTA methods report. Series of the German Institute for Medical Documentation and Information commissioned by the Federal Ministry of Health and Social Security] (German; Original Title:Entscheidungsanalytische Modelle zur Sicherung der Übertragbarkeit internationaler Evidenz von HTA auf den Kontext des deutschen Gesundheitssystems). GMS Health Technol Assess 2005;1(Doc03):1-6.

Boese-O'Reilly S, Lettmeier B, Roider G, Siebert U, Drasch G. Mercury in breast milk - A health hazard for infants in gold mining areas? Int J Hyg Environ Health 2008; 211(5-6):615-23.

Siebert U, Zietemann V, Sroczynski G. Pharmacogenomics bias - systematic distortion of study results by genetic heterogeneity. [German; original title: Pharmacogenomics-Bias - Systematische Verzerrungen in Studienergebnissen durch genetische Heterogenität]. Health Technology Assessment Vol. 63. (Series of the German Institute for Medical Documentation and Information commissioned by the Federal Ministry of Health). 67 pages. Cologne: DIMDI, 2008.

Stephanie AK, Stock MD, Stollenwerk B, Redaelli M, Civello D, Lauterbach KW. Sex differences in treatment patterns of six chronic diseases: An analysis from the German Statutory Health Insurance. Journal of Women's Health 2008:17:3;Doi: 10.1089/jwh.2007.0422.

Janne d'Othée B, Siebert U, Cury R, Jadvar H, Dunn EJ, Hoffmann U. A systematic review on diagnostic accuracy of CT-based detection of significant coronary artery disease. Eur J Radiol. 2008;65(3):449-61.

Lüngen M. Stollenwerk B. Messner P. Lauterbach KW. Gerber A. Waitingtimes for elective treatments according to insurance status: A randomized empirical study in Germany. International Journal for Equity in Health 2008:7:1; doi:10.1186/1475-9276-7-1. 

Vauth C, Haverkamp A, Mittendorf T, Siebert U, Schulenburg JM, Krauth C. Das Kompetenznetz Hepatitis - Methodische Ansätze und erste Ergebnisse der gesundheitsökonomischen Begleitforschung. Gesundheitsökonomie & Qualitätsmanagement 2007;12(4):203-206.

von der Schulenburg J, Greiner W, Jost F, Klusen N, Kubin M, Leidl R, Mitten-Lewis S, Rebscher H, Schoffski O, Vauth C, Vollmer T, Wahler S, Wasem J, Weber CC, all members of the Hanover Consensus Panel. [German recommendations on health economic evaluation - third and updated version of the Hanover Consensus]. Gesundheitsokonomie und Qualitatsmanagement 2007;12:285-290.

Dodel R, Peter H, Spottke A, Althaus A, Siebert U, Walbert T, Kesper K, Becker HF, Mayer G. Health-related quality of life in patients with narcolepsy. Sleep Medicine 2007:8(7-8):733-41.

Meissner OA, Schmedt CG, Hunger K, Hetterich H, Sroka R, Rieber J, Babaryka G, Steckmeier BM, Reiser M, Siebert U, Mueller-Lisse U. Endovascular optical coherence tomography ex vivo: venous wall anatomy and tissue alterations after endovenous therapy. Eur Radiol 2007;17(9):2384-93.

Schneider A, Schwarz TF, Hammerschmidt T, Rash RM, Siebert U.[Treatment patterns and costs of unclear and abnormal cervicalconditions in Germany]. [German] Geburtshilfe und Frauenheilkunde 2007;67(8):859-865. 

Schneider A, Hammerschmidt T, Schwarz TF, Rogoza RM, Ferko N,Siebert U. [Long-term public health impact of vaccination againstcervical cancer in Germany]. [German] Geburtshilfe und Frauenheilkunde 2007;67(8):850-858. 

Schneider A, Schwarz TF, Hammerschmidt T, Siebert U. [Impact of vaccination against oncogenic human papillomavirus on the incidence and mortality of cervical cancer in Germany]. [German] Medizinische Klinik 2007; 102(7):515-23.

Fearon WF, Tonino PA, De Bruyne B, Siebert U, Pijls NHJ, for the FAME Study Investigators. Rationale and design of the fractional flow reserve versus angiography for multivessel evaluation (FAME) study. American Heart Journal 2007;154(4):632-6. Correction: Am Heart J 2007;154(6):1243.

König A, Leibig M, Rieber J, Schiele TM, Theisen K, Siebert U, Gothe RM, Klauss V. Randomized comparison of dexamethasone-eluting stents with bare metal stent implantation in patients with acute coronary syndrome: serial angiographic and sonographic analysis. American Heart Journal 2007;153(6):979.e1-8. 

Müller T, Koppikar S, Taylor RM, Carragher F, Schlenck B, Heinz-Erian P, Kronenberg F, Ferenci P, Tanner S, Siebert U, Staudinger R, Mieli-Vergani G, Dhawan A. Re-evaluation of the penicillamine challenge test in the diagnosis of Wilson's disease in children. J Hepatol 2007; 47(2):270-6. 

Dodel R, Peter H, Spottke A, Althaus A, Siebert U, Walbert T, Kesper K, Becker HF, Mayer G. Health-related quality of life in patients with narcolepsy. Sleep Med 2007;8(7-8):733-41. 

Schrag A, Dodel R, Spottke A, Bornschein B, Siebert U, Quinn NP Titel: Rate of clinical progression in Parkinson's disease. A prospective study. Mov Disord 2007; 22(7):938-45. 

Zietemann V, Zietemann P, Weitkunat R, Kwetkat A. [Relation between certain diseases and frequency of depression in geriatric patients]. Nervenarzt 2007;78(6):657-64.

Siebert U. Cost-Effectiveness. In: King and Yeung (eds.). Interventional Cardiology. McGraw-Hill, New York: 2007, 767-82.

Mühlberger N, Sroczynski G, Lettmeier B, Schwarzer R, Esteban E, Conrads-Frank A, Zeuzem S, Siebert U. Results of the PanEuropean Hepatitis C Project. Presentation at the China HCV Management Forum Beijing, 16 November 2007.

Boese-O'Reilly S. Continuous medical education (CME): do we need CME for paediatric environmental medicine in Europe? Int J Hyg Environ Health 2007;210(5):531-4.

Böse-O'Reilly S, Heudorf U, Lob-Corzilius T, von Muhlendahl KE, Otto M, Schmidt S. Children's environment in Central Europe: threats and chances. Int J Hyg Environ Health 2007;210(5):503-7.

Drasch G, Boese-O'Reilly S, Illig S. Increase of renal excretion of organo-mercury compounds like methlymercury by DMPS (2,3-Dimercapto-1-propanesulfonic acid, Dimaval). Clin Toxicol (Phila) 2007;45(3):266-9.

Boese-O'Reilly S, Glück-Kretschmer C, Reese I, Gießler-Fichtner O. Neurodermitisschulung in der kinder- und jugendärztlichen Praxis. Pädiatrische Allergologie 2007;10(Sonderheft Asthma und Neurodermitisschulung):45-46.

Boese-O'Reilly S, Shimkin MKE. Taking action to protect children from environmental hazards. In: Pronczuk-Garbino J, editor. Children's health and the environment - a global perspective. Geneva: WHO press; 2005. p. 253-272.

Baierl V, Baumgartner S, Pollinger B, Leibig M, Rieber J, Konig A, Krotz F, Sohn HY, Siebert U, Haimerl W, Duhmke E, Theisen K, Klauss V, Schiele TM. Three-year clinical follow-up after strontium-90/yttrium-90 Beta-irradiation for the treatment of in-stent coronary restenosis. Am J Cardiol 2005;96(10):1399-403.

Brandstaedter D, Spieker S, Ulm G, Siebert U, Eichhorn TE, Krieg JC, Eggert K, Oertel WH. Development and evaluation of the Parkinson Psychosis Questionnaire: A screening-instrument for the early diagnosis of drug-induced psychosis in Parkinson's disease. J Neurol 2005; 252(9):1060-6.

Erhard I, Rieber J, Jung P, Hacker M, Schiele T, Stempfle HU, König A, Baylacher M, Theisen K, Siebert U, Klauss V. The validation of fractional flow reserve in patients with coronary multivessel disease: a comparison with SPECT and contrast-enhanced dobutamine stress echocardiography. Zeitschrift fur Kardiologie 2005;94(5):321-7.

Lippert B, Berger K, Berntorp E, Giangrande P, van den Berg M, Schramm W, Siebert U, and the European Haemophilia Economic Study Group. Cost effectiveness of haemophilia treatment: A Cross-national assessment. Blood Coagul Fibrinolysis 2005;16(7):477-85.

Rieber J, Gockel K, Koschyk D, Erhard I, Koenig A, Schiele TM, Theisen K, Siebert U, Klauss V. Application, feasibility, and efficacy of a combined intravascular ultrasound and stent delivery system: results from a prospective multicenter trial. J Interv Cardiol 2005;18(5):367-74. 

Von Campenhausen S, Bornschein B, Wick R, Bötzel K, Sampaio C, Poewe W, Olesen J, Oertel W, Siebert U, Berger K, Dodel R. Prevalence and incidence of Parkinson's disease in Europe. Eur Neuropsychopharmacol 2005;15(4):473-90. 

Spottke AE, Reuter M, Machat O, Bornschein B, von Campenhausen S, Berger K, Koehne-Volland R, Rieke J, Simonow A, Brandstaedter D, Siebert U, Oertel WH, Ulm G, Dodel R. Cost of illness and its predictors for Parkinson's disease in Germany. Pharmacoeconomics 2005; 23(8):817-36.

Stempfle HU, König A, Drescher E, Siebert U, Klauss V. Discrepancy between morphologic and functional criteria of optimal stent deployment using intravascular ultrasound and pressure derived myocardial fractional flow reserve. Int J Cardiovasc Intervent 2005;7(2):101-7.

Schiele TM, König A, Rieber J, Erhard I, Leibig M, Theisen K, Siebert U, Klauss V. Sirolimus-eluting stent implantation and beta-irradiation for the treatment of in-stent restenotic lesions: comparison of underlying mechanisms of acute gain and late loss as assessed by volumetric intravascular ultrasound. Am Heart J 2005;150(2):351-7.

Siebert U. Using decision-analytic modelling to transfer international evidence from health technology assessment to the context of the German health care system. GMS Health Technol Assess 2005;1(Doc03):1-6.

Siebert U. [Using decision-analytic modelling to transfer international evidence from health technology assessment to the context of the German health care system. A HTA methods report. Series of the German Institute for Medical Documentation and Information commissioned by the Federal Ministry of Health and Social Security] (German; Original Title:Entscheidungsanalytische Modelle zur Sicherung der Übertragbarkeit internationaler Evidenz von HTA auf den Kontext des deutschen Gesundheitssystems). GMS Health Technol Assess 2005;1(Doc03):1-6.

Erhard I, Rieber J, Jung P, Hacker M, Schiele T, Stempfle HU, Konig A, Baylacher M, Theisen K, Siebert U, Klauss V Institution. The validation of fractional flow reserve in patients with coronary multivessel disease: a comparison with SPECT and contrast-enhanced dobutamine stressechocardiography. Zeitschrift für Kardiologie 2005;94(5):321-7.

Siebert U, Sroczynski G, Wasem J, Greiner W, Ravens-Sieberer U, Aidelsburger P, Kurth BM, Bullinger M, Graf von der Schulenburg JM, Wong JB, Rossol S. Using competence network collaboration and decision-analytic modeling to assess the cost-effectiveness of interferon alpha-2b plus ribavirin as initial treatment of chronic hepatitis C in Germany. Eur J Health Econ 2005;2(6);112-23. 

Gazelle GS, McMahon PM, Siebert U, Beinfeld MT. Cost-effectiveness analysis in the assessment of diagnostic imaging technologies. Radiology 2005;235(2):361-370.

Lindgren P, von Campenhausen S, Spottke EA, Siebert U, Dodel R. Cost of Parkinson?s disease in Europe. European Journal of Neurology 2005;12 (Suppl. 1): 68-73.

Meissner OA, Rieger J, Weber C, Siebert U, Steckmeier B, Reiser M, Schoenberg SO. Critical limb ischemia: hybrid-MR angiography compared with digital subtraction angiography. Radiology 2005;235(1):308-18.

Grill E, Hessel F, Siebert U, Schnell-Inderst P, Kunze S, Nickisch A, Wasem J. Comparing the clinical effectiveness of different new-born hearing screening strategies. A decision analysis. BMC Public Health 2005;5(1:12.

Klauss V, Erdin P, Rieber J, Leibig M, Stempfle HU, König A, Baylacher M, Theisen K, Haufe MC, Sroczynski G, Schiele T, Siebert U. Fractional flow reserve for the prediction of cardiac events after coronary stent implantation: results of a multivariate analysis. Heart (British Cardiac Society) 2005;91(2):203-206.

Siebert U, Wasem J, Rossol S, Sroczynski G, Aidelsburger P, Ravens-Sieberer U, Kurth BM, Manns MP, McHutchison JG, Wong JB [Letter]. Antiviral treatment initiation costs in chronic hepatitis C. Gut 2005;54(1):172-3.

Siebert U, Sroczynski G, German Hepatitis C Model (GEHMO) Group, HTA Expert Panel on Hepatitis C. Effectiveness and cost-effectiveness of initial combination therapy with interferon/peginterferon plus ribavirin in patients with chronic hepatitis C in Germany: a health technology assessment commissioned by the German Federal Ministry of Health and Social Security. Int J Tech Assess Health Care 2005;21(1):55-65.

Hessel F, Grabein K, Schnell-Inderst P, Siebert U, Caspary W, Wasem J. Extracorporal artificial liver support systems in patients with acute liver failure or acute ecompensation of chronic liver disease. Extracorporal artificial liver support systems in patients with acute liver failure or acute-on-chronic liver failure. [German; original title: Extrakorporale artifizielle Leberunterstützungssysteme bei akutem Leberversagen oder einer akuten Dekompensation eines chronischen Leberleidens]. Health Technology Assessment. (Series of the German Institute for Medical Documentation and Information).

Siebert U. Using Decision-Analytic Modelling to Transfer International Evidence from Health Technology Assessment to the Context of the German Health Care System. A HTA Methods Report [German; original title: Entscheidungsanalytische Modelle zur Sicherung der Übertragbarkeit internationaler Evidenz aus HTA auf den Kontext des deutschen Gesundheitssystems. Ein HTA Methodenreport] Health Technology Assessment Vol 15. (Series of the German Institute for Medical Documentation and Information commissioned by the Federal Ministry of Health and Social Security). 90 pages. Köln: DIMDI, 2005.